List of life saving transplantations

The ultimate goal of our service is to use stored stem cells for transplantations. For this reason we are proud to have been by our customers’ side time and time again during difficult circumstances by collecting, storing and preparing life-saving biological material for transplantation.

Filter by

No. Cell source Indication Area of medicine Year Type of therapy Country Recipient age
1 cord blood CD40 ligand deficiency hematology 2017 standard therapy Turkey 10
2 cord blood talassemia major hematology 2017 standard therapy Turkey 4
3 cord blood talassemia major hematology 2017 standard therapy Turkey 4
4 autologous cord blood cerebral palsy neurology 2017 experimental therapy Poland 2
5 autologous cord blood cerebral palsy neurology 2017 experimental therapy Poland 5
6 autologous cord blood cerebral palsy neurology 2017 experimental therapy Poland 10
7 autologous cord blood autism neurology 2017 experimental therapy Poland 4
8 cord blood relapse of acute lymphoblastic leukemia hematology 2017 standard therapy Poland 7
9 autologous cord blood cerebral palsy neurology 2017 experimental therapy Poland 7
10 autologous cord blood autism neurology 2017 experimental therapy Poland 6
11 autologous cord blood autism neurology 2017 experimental therapy Poland 7
12 autologous cord blood autism neurology 2017 experimental therapy Poland 5
13 autologous cord blood autism neurology 2017 experimental therapy Poland 4
14 autologous cord blood autism neurology 2017 experimental therapy Poland 4
15 cord blood acute myeloid leukemia hematology 2016 standard therapy Jordan 6
16 autologous cord blood autism neurology 2016 experimental therapy Poland 6
17 cord blood acute lymphoblastic leukemia hematology 2016 standard therapy Hungary 7
18 cord blood acute lymphoblastic leukemia hematology 2015 standard therapy Poland 4
19 cord blood acute lymphoblastic leukemia hematology 2014 standard therapy Turkey 7
20 cord blood aplastic anaemia hematology 2013 standard therapy Poland 3
21 cord blood acute myeloid leukemia hematology 2013 standard therapy Poland 3
22 cord blood beta-talassemia; agranulocytosis hematology 2013 standard therapy Turkey 8
23 cord blood X - linked lymphoproliferative syndrome hematology 2013 standard therapy Poland 10
24 cord blood severe aplastic anaemia hematology 2012 standard therapy Hungary 3
25 cord blood anaemia, talassemia major hematology 2012 standard therapy Turkey 6
26 cord blood talassemia major, acute lymphoblastic leukemia hematology 2012 standard therapy Turkey 4
27 cord blood T-acute lymphoblastic leukemia hematology 2012 standard therapy Turkey 5
28 cord blood Fanconi anemia hematology 2011 standard therapy Poland 12
29 cord blood acute myeloid leukemia hematology 2011 standard therapy Hungary 2
30 cord blood acute lymphoblastic leukemia hematology 2011 standard therapy Poland 5
31 cord blood histiocytosis hematology 2011 standard therapy Poland 3
32 cord blood chronic granulomatous disease hematology 2011 standard therapy Poland 8
33 cord blood pre -B acute lymphoblastic leukemia hematology 2010 standard therapy Hungary 2
34 cord blood myelodysplastic syndrome hematology 2009 standard therapy Poland 5
35 cord blood acute lymphoblastic leukemia hematology 2008 standard therapy Poland 5
36 autologous cord blood cerebral ischemia neurology 2008 experimental therapy Poland 2
37 cord blood neuroblastoma hematology 2007 standard therapy Poland 8
38 cord tissue (Wharton's jelly) cerebral palsy neurology 2017 experimental therapy Poland 2,10
39 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2017 experimental therapy Poland 67,11
40 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2017 experimental therapy Poland 37,9
41 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2017 experimental therapy Poland 71,7
42 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2017 experimental therapy Poland no data
43 cord tissue (Wharton's jelly) autism neurology 2017 experimental therapy Poland 7,11
44 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2017 experimental therapy Poland 47,6
45 cord tissue (Wharton's jelly) spinocerebellar ataxia neurology 2017 experimental therapy Poland 44,1
46 cord tissue (Wharton's jelly) spinal cord injury orthopedics 2017 experimental therapy Poland 34,11
47 cord tissue (Wharton's jelly) retinitis pigmentosa ophthalmology 2017 experimental therapy Poland 58,10
48 cord tissue (Wharton's jelly) retinitis pigmentosa ophthalmology 2017 experimental therapy Poland 49,0
49 cord tissue (Wharton's jelly) Stargardt's disease ophthalmology 2017 experimental therapy Poland 37,4
50 cord tissue (Wharton's jelly) muscular dystrophy neurology 2017 experimental therapy Poland 37,7
51 cord tissue (Wharton's jelly) muscular dystrophy neurology 2017 experimental therapy Poland 26,11
52 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2017 experimental therapy Poland 56,7
53 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2017 experimental therapy Poland 48,11
54 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2017 experimental therapy Poland 46,3
55 cord tissue (Wharton's jelly) cartilage damage orthopedics 2017 experimental therapy Poland 61,5
56 cord tissue (Wharton's jelly) spinal cord injury orthopedics 2017 experimental therapy Poland 34,1
57 cord tissue (Wharton's jelly) sclerosis multiplex neurology 2017 experimental therapy Poland 52,9
58 cord tissue (Wharton's jelly) atrophy of the optic nerves ophthalmology 2017 experimental therapy Poland 23,9
59 cord tissue (Wharton's jelly) Stargardt's disease ophthalmology 2017 experimental therapy Poland 31,6
60 cord tissue (Wharton's jelly) age-related macular degeneration ophthalmology 2017 experimental therapy Poland 33,4
61 cord tissue (Wharton's jelly) tetraparesis spastica neurology 2017 experimental therapy Poland 29,4
62 cord tissue (Wharton's jelly) spinal cord injury orthopedics 2017 experimental therapy Poland 24,9
63 cord tissue (Wharton's jelly) spinal muscular atrophy neurology 2017 experimental therapy Poland 10,6
64 cord tissue (Wharton's jelly) Stargardt's disease ophthalmology 2017 experimental therapy Poland 30,0
65 cord tissue (Wharton's jelly) retinitis pigmentosa ophthalmology 2017 experimental therapy Poland 56,8
66 cord tissue (Wharton's jelly) retinitis pigmentosa ophthalmology 2017 experimental therapy Poland 65,2
67 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2017 experimental therapy Poland 45,9
68 cord tissue (Wharton's jelly) dystrophia progressiva pseudohypertrophica /DMD neurology 2017 experimental therapy Poland 28,6
69 cord tissue (Wharton's jelly) limb-girdle muscular dystrophy neurology 2017 experimental therapy Poland 44,2
70 cord tissue (Wharton's jelly) spinal muscular atrophy neurology 2017 experimental therapy Poland 41,4
71 cord tissue (Wharton's jelly) limb-girdle muscular dystrophy neurology 2017 experimental therapy Poland 25,8
72 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2017 experimental therapy Poland 75,9
73 cord tissue (Wharton's jelly) Stargardt's disease ophthalmology 2017 experimental therapy Poland 23,7
74 cord tissue (Wharton's jelly) retinitis pigmentosa ophthalmology 2017 experimental therapy Poland 43,4
75 cord tissue (Wharton's jelly) optic atrophy ophthalmology 2017 experimental therapy Poland 39,0
76 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2017 experimental therapy Poland 51,3
77 cord tissue (Wharton's jelly) spinal cord injury orthopedics 2017 experimental therapy Poland 39,0
78 cord tissue (Wharton's jelly) retinitis pigmentosa ophthalmology 2017 experimental therapy Poland 42,11
79 cord tissue (Wharton's jelly) optic atrophy ophthalmology 2017 experimental therapy Poland 30,9
80 cord tissue (Wharton's jelly) spinal muscular atrophy neurology 2017 experimental therapy Poland 12,11
81 cord tissue (Wharton's jelly) spinal muscular atrophy neurology 2017 experimental therapy Poland 8,5
82 cord tissue (Wharton's jelly) gonarthrosis orthopedics 2017 experimental therapy Poland 58,9
83 cord tissue (Wharton's jelly) cri du chat syndrome neurology 2017 experimental therapy Poland 8,6
84 cord tissue (Wharton's jelly) cerebral palsy neurology 2017 experimental therapy Poland 18,7
85 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2017 experimental therapy Poland 59,8
86 cord tissue (Wharton's jelly) muscular dystrophy neurology 2017 experimental therapy Poland 22,1
87 cord tissue (Wharton's jelly) dystrophia progressiva pseudohypertrophica /DMD neurology 2017 experimental therapy Poland 28,11
88 cord tissue (Wharton's jelly) epilepsia neurology 2017 experimental therapy Poland 3,1
89 cord tissue (Wharton's jelly) cranium bifidum neurology 2017 experimental therapy Poland 5,2
90 cord tissue (Wharton's jelly) transverse myelitis neurology 2017 experimental therapy Poland 8,3
91 cord tissue (Wharton's jelly) syringomielia neurology 2017 experimental therapy Poland 42,6
92 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2017 experimental therapy Poland 64,9
93 cord tissue (Wharton's jelly) sclerosis multiplex neurology 2017 experimental therapy Poland 47,2
94 cord tissue (Wharton's jelly) limb-girdle muscular dystrophy neurology 2017 experimental therapy Poland 38,5
95 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2017 experimental therapy Poland 56,7
96 cord tissue (Wharton's jelly) autism neurology 2017 experimental therapy Poland 13,4
97 cord tissue (Wharton's jelly) encephalopathy neurology 2017 experimental therapy Poland 21,10
98 cord tissue (Wharton's jelly) encephalopathy neurology 2017 experimental therapy Poland 5,0
99 cord tissue (Wharton's jelly) retinitis pigmentosa ophthalmology 2017 experimental therapy Poland 41,0
100 cord tissue (Wharton's jelly) retinitis pigmentosa ophthalmology 2017 experimental therapy Poland 52,1
101 cord tissue (Wharton's jelly) cerebral palsy; neonatal cerebral leukomalacia neurology 2017 experimental therapy Poland 1,9
102 cord tissue (Wharton's jelly) autism neurology 2017 experimental therapy Poland 11,11
103 cord tissue (Wharton's jelly) limb-girdle muscular dystrophy neurology 2017 experimental therapy Poland 26,10
104 cord tissue (Wharton's jelly) autism neurology 2017 experimental therapy Poland 9,1
105 cord tissue (Wharton's jelly) cerebellar syndrome neurology 2017 experimental therapy Poland 11,5
106 cord tissue (Wharton's jelly) congenital fiber-type disproportion myopathy neurology 2017 experimental therapy Poland 1,10
107 cord tissue (Wharton's jelly) chronic myeloid leukemia hematology 2017 experimental therapy Poland 5,11
108 cord tissue (Wharton's jelly) retinitis pigmentosa ophthalmology 2017 experimental therapy Poland 61,5
109 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2017 experimental therapy Poland 40,11
110 cord tissue (Wharton's jelly) retinitis pigmentosa ophthalmology 2017 experimental therapy Poland 48,1
111 cord tissue (Wharton's jelly) spina bifida neurology 2017 experimental therapy Poland 1,11
112 cord tissue (Wharton's jelly) muscular dystrophy neurology 2017 experimental therapy Poland 37,11
113 cord tissue (Wharton's jelly) arthrogryposis multiplex congenita neurology 2017 experimental therapy Poland 1,7
114 cord tissue (Wharton's jelly) encephalopathy; cerebral palsy neurology 2017 experimental therapy Poland 4,4
115 cord tissue (Wharton's jelly) cerebral palsy; epilepsy neurology 2017 experimental therapy Poland 5,8
116 cord tissue (Wharton's jelly) spinal cord injury orthopedics 2017 experimental therapy Poland 6,4
117 cord tissue (Wharton's jelly) cerebral palsy neurology 2017 experimental therapy Poland 15,4
118 cord tissue (Wharton's jelly) traumatic brain injury neurology 2017 experimental therapy Poland 9,4
119 cord tissue (Wharton's jelly) no bone adhesion orthopedics 2017 experimental therapy Poland 14,1
120 cord tissue (Wharton's jelly) no bone adhesion orthopedics 2017 experimental therapy Poland 17,11
121 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2017 experimental therapy Poland 69,10
122 cord tissue (Wharton's jelly) spinal muscular atrophy neurology 2017 experimental therapy Poland 24,9
123 cord tissue (Wharton's jelly) optic atrophy ophthalmology 2017 experimental therapy Poland 37,7
124 cord tissue (Wharton's jelly) retinitis pigmentosa ophthalmology 2017 experimental therapy Poland 31,1
125 cord tissue (Wharton's jelly) retinitis pigmentosa ophthalmology 2017 experimental therapy Poland 52,11
126 cord tissue (Wharton's jelly) Stargardt's disease ophthalmology 2017 experimental therapy Poland 27,11
127 cord tissue (Wharton's jelly) Stargardt's disease ophthalmology 2017 experimental therapy Poland 45,4
128 cord tissue (Wharton's jelly) muscular dystrophy neurology 2017 experimental therapy Poland 34,10
129 cord tissue (Wharton's jelly) muscular dystrophy neurology 2017 experimental therapy Poland 31,6
130 cord tissue (Wharton's jelly) hydrocephalus; neonatal cerebral leukomalacia neurology 2017 experimental therapy Poland 2,3
131 cord tissue (Wharton's jelly) autism neurology 2017 experimental therapy Poland 6,3
132 cord tissue (Wharton's jelly) autism neurology 2017 experimental therapy Poland 7,11
133 cord tissue (Wharton's jelly) delayed psychomotor development neurology 2017 experimental therapy Poland 3,5
134 cord tissue (Wharton's jelly) delayed psychomotor development neurology 2017 experimental therapy Poland 6,3
135 cord tissue (Wharton's jelly) syndrom IFAP hematology 2017 experimental therapy Poland 3,5
136 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2017 experimental therapy Poland 52,0
137 cord tissue (Wharton's jelly) acute graft versus host disease hematology 2017 experimental therapy Poland 13,0
138 cord tissue (Wharton's jelly) acute graft versus host disease hematology 2017 experimental therapy Poland 11,10
139 cord tissue (Wharton's jelly) optic atrophy ophthalmology 2017 experimental therapy Poland 66,11
140 cord tissue (Wharton's jelly) ischemia within the optic nerve ophthalmology 2017 experimental therapy Poland 37,11
141 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2017 experimental therapy Poland 35,1
142 cord tissue (Wharton's jelly) cerebral palsy neurology 2017 experimental therapy Poland 4,11
143 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2017 experimental therapy Poland 77,2
144 cord tissue (Wharton's jelly) retinitis pigmentosa ophthalmology 2017 experimental therapy Poland 36,11
145 cord tissue (Wharton's jelly) retinitis pigmentosa ophthalmology 2017 experimental therapy Poland 63,11
146 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2017 experimental therapy Poland 35,6
147 cord tissue (Wharton's jelly) retinitis pigmentosa ophthalmology 2017 experimental therapy Poland 31,9
148 cord tissue (Wharton's jelly) cerebral palsy neurology 2017 experimental therapy Poland 31,9
149 cord tissue (Wharton's jelly) autism neurology 2017 experimental therapy Poland 10,2
150 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2017 experimental therapy Poland 33,5
151 cord tissue (Wharton's jelly) cerebral palsy neurology 2017 experimental therapy Poland 5,7
152 cord tissue (Wharton's jelly) cerebral palsy neurology 2017 experimental therapy Poland 12,5
153 cord tissue (Wharton's jelly) cerebral palsy neurology 2017 experimental therapy Poland 5,9
154 cord tissue (Wharton's jelly) cerebral palsy neurology 2017 experimental therapy Poland 3,3
155 cord tissue (Wharton's jelly) delayed psychomotor development neurology 2017 experimental therapy Poland 5,0
156 cord tissue (Wharton's jelly) hypoxia-ischemic encephalopathy neurology 2017 experimental therapy Poland 1,9
157 cord tissue (Wharton's jelly) Krabbe disease neurology 2017 experimental therapy Poland 6,3
158 cord tissue (Wharton's jelly) spinocerebellar ataxia neurology 2017 experimental therapy Poland 24,6
159 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2017 experimental therapy Poland 51,6
160 cord tissue (Wharton's jelly) retinitis pigmentosa ophthalmology 2017 experimental therapy Poland 45,5
161 cord tissue (Wharton's jelly) optic atrophy ophthalmology 2017 experimental therapy Poland 31,5
162 cord tissue (Wharton's jelly) Stargardt's disease ophthalmology 2017 experimental therapy Poland 48,10
163 cord tissue (Wharton's jelly) muscular dystrophy neurology 2017 experimental therapy Poland 62,5
164 cord tissue (Wharton's jelly) cerebellar syndrome neurology 2017 experimental therapy Poland 60,5
165 cord tissue (Wharton's jelly) cerebral palsy neurology 2017 experimental therapy Poland 6,1
166 cord tissue (Wharton's jelly) autism neurology 2017 experimental therapy Poland 4,8
167 cord tissue (Wharton's jelly) spina bifida neurology 2017 experimental therapy Poland 6,4
168 cord tissue (Wharton's jelly) spina bifida neurology 2017 experimental therapy Poland 6,3
169 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2017 experimental therapy Poland 46,0
170 cord tissue (Wharton's jelly) retinitis pigmentosa ophthalmology 2017 experimental therapy Poland 49,1
171 cord tissue (Wharton's jelly) condition after encephalitis neurology 2017 experimental therapy Poland 19,7
172 cord tissue (Wharton's jelly) muscular dystrophy neurology 2017 experimental therapy Poland 35,4
173 cord tissue (Wharton's jelly) spina bifida neurology 2017 experimental therapy Poland 1,10
174 cord tissue (Wharton's jelly) autism neurology 2017 experimental therapy Poland 6,8
175 cord tissue (Wharton's jelly) encephalopathy; cerebral palsy neurology 2017 experimental therapy Poland 1,5
176 cord tissue (Wharton's jelly) autism neurology 2017 experimental therapy Poland 7,0
177 cord tissue (Wharton's jelly) cerebral palsy neurology 2017 experimental therapy Poland 13,6
178 cord tissue (Wharton's jelly) muscular dystrophy neurology 2017 experimental therapy Poland 6,7
179 cord tissue (Wharton's jelly) facio-scapulo-humeral muscular dystrophy neurology 2017 experimental therapy Poland 32,3
180 cord tissue (Wharton's jelly) sclerosis multiplex neurology 2017 experimental therapy Poland 46,9
181 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2017 experimental therapy Poland 54,10
182 cord tissue (Wharton's jelly) dystrophia myotonica neurology 2017 experimental therapy Poland 41,11
183 cord tissue (Wharton's jelly) global developmental delay neurology 2017 experimental therapy Poland 4,7
184 cord tissue (Wharton's jelly) optic neuropathy ophthalmology 2017 experimental therapy Poland 56,4
185 cord tissue (Wharton's jelly) spina bifida neurology 2017 experimental therapy Poland 4,1
186 cord tissue (Wharton's jelly) spina bifida neurology 2017 experimental therapy Poland 3,6
187 cord tissue (Wharton's jelly) facio-scapulo-humeral muscular dystrophy neurology 2017 experimental therapy Poland 33,4
188 cord tissue (Wharton's jelly) muscular dystrophy neurology 2017 experimental therapy Poland 42,1
189 cord tissue (Wharton's jelly) acute graft versus host disease hematology 2017 experimental therapy Poland 2,4
190 cord tissue (Wharton's jelly) optic neuropathy ophthalmology 2017 experimental therapy Poland 30,11
191 cord tissue (Wharton's jelly) optic atrophy ophthalmology 2017 experimental therapy Poland 39,7
192 cord tissue (Wharton's jelly) autism neurology 2017 experimental therapy Poland 4,8
193 cord tissue (Wharton's jelly) cerebral palsy neurology 2017 experimental therapy Poland 8,2
194 cord tissue (Wharton's jelly) spina bifida neurology 2017 experimental therapy Poland 3,4
195 cord tissue (Wharton's jelly) spina bifida neurology 2017 experimental therapy Poland 2,11
196 cord tissue (Wharton's jelly) delayed psychomotor development neurology 2017 experimental therapy Poland 7,9
197 cord tissue (Wharton's jelly) arthrogryposis multiplex congenita neurology 2017 experimental therapy Poland 3,5
198 cord tissue (Wharton's jelly) dystrophia myotonica neurology 2017 experimental therapy Poland 3,2
199 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2017 experimental therapy Poland 63,2
200 cord tissue (Wharton's jelly) optic atrophy ophthalmology 2017 experimental therapy Poland 76,10
201 cord tissue (Wharton's jelly) dystrophia progressiva pseudohypertrophica /BMD neurology 2017 experimental therapy Poland 23,9
202 cord tissue (Wharton's jelly) cerebral palsy neurology 2017 experimental therapy Poland 3,7
203 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2017 experimental therapy Poland 43,8
204 cord tissue (Wharton's jelly) optic neuropathy ophthalmology 2017 experimental therapy Poland 74,5
205 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2017 experimental therapy Poland 64,7
206 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2017 experimental therapy Poland 51,6
207 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2017 experimental therapy Poland 70,11
208 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2017 experimental therapy Poland 65,1
209 cord tissue (Wharton's jelly) encephalopathy neurology 2017 experimental therapy Poland 5,5
210 cord tissue (Wharton's jelly) cerebral palsy neurology 2017 experimental therapy Poland 8,4
211 cord tissue (Wharton's jelly) cerebral palsy neurology 2017 experimental therapy Poland 15,1
212 cord tissue (Wharton's jelly) spina bifida neurology 2017 experimental therapy Poland 5,8
213 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2017 experimental therapy Poland 51,3
214 cord tissue (Wharton's jelly) muscular dystrophy neurology 2017 experimental therapy Poland 12,10
215 cord tissue (Wharton's jelly) retinitis pigmentosa ophthalmology 2017 experimental therapy Poland 26,9
216 cord tissue (Wharton's jelly) cerebral palsy neurology 2017 experimental therapy Poland 18,4
217 cord tissue (Wharton's jelly) autism neurology 2017 experimental therapy Poland 10,8
218 cord tissue (Wharton's jelly) autism neurology 2017 experimental therapy Poland 13,1
219 cord tissue (Wharton's jelly) cerebral palsy neurology 2017 experimental therapy Poland 7,9
220 cord tissue (Wharton's jelly) cerebral palsy neurology 2017 experimental therapy Poland 5,5
221 cord tissue (Wharton's jelly) cerebral palsy neurology 2017 experimental therapy Poland 3,7
222 cord tissue (Wharton's jelly) cerebral palsy neurology 2017 experimental therapy Poland 3,5
223 cord tissue (Wharton's jelly) cerebral palsy neurology 2017 experimental therapy Poland 5,1
224 cord tissue (Wharton's jelly) cerebral palsy neurology 2017 experimental therapy Poland 3,4
225 cord tissue (Wharton's jelly) Devic’s disease neurology 2017 experimental therapy Poland 45,2
226 cord tissue (Wharton's jelly) limb-girdle muscular dystrophy neurology 2017 experimental therapy Poland 31,3
227 cord tissue (Wharton's jelly) spina bifida neurology 2017 experimental therapy Poland 6,10
228 cord tissue (Wharton's jelly) cerebral palsy neurology 2017 experimental therapy Poland 5,3
229 cord tissue (Wharton's jelly) epilepsia, autism neurology 2017 experimental therapy Poland 6,0
230 cord tissue (Wharton's jelly) myopathy of congenital fiber type disproportion; damage to the central nervous system neurology 2017 experimental therapy Poland 2,2
231 cord tissue (Wharton's jelly) cerebral palsy neurology 2017 experimental therapy Poland 2,7
232 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2017 experimental therapy Poland 68,1
233 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2017 experimental therapy Poland 59,3
234 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2017 experimental therapy Poland 49,1
235 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2017 experimental therapy Poland 60,1
236 cord tissue (Wharton's jelly) global developmental delay neurology 2017 experimental therapy Poland 7,11
237 cord tissue (Wharton's jelly) spina bifida neurology 2017 experimental therapy Poland 2,8
238 cord tissue (Wharton's jelly) autism neurology 2017 experimental therapy Poland 4,11
239 cord tissue (Wharton's jelly) muscular dystrophy neurology 2017 experimental therapy Poland 10,8
240 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2017 experimental therapy Poland 56,7
241 cord tissue (Wharton's jelly) sclerosis multiplex neurology 2017 experimental therapy Poland 38,0
242 cord tissue (Wharton's jelly) sclerosis multiplex neurology 2017 experimental therapy Poland 25,2
243 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2017 experimental therapy Poland 58,7
244 cord tissue (Wharton's jelly) cerebral palsy neurology 2017 experimental therapy Poland 3,2
245 cord tissue (Wharton's jelly) cerebral palsy neurology 2017 experimental therapy Poland 4,7
246 cord tissue (Wharton's jelly) autism neurology 2017 experimental therapy Poland 4,8
247 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2017 experimental therapy Poland 63,0
248 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2017 experimental therapy Poland 62,9
249 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2017 experimental therapy Poland 57,9
250 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2017 experimental therapy Poland 59,11
251 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2017 experimental therapy Poland 46,5
252 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2017 experimental therapy Poland 53,9
253 cord tissue (Wharton's jelly) leukodystrophy neurology 2017 experimental therapy Poland 7,1
254 cord tissue (Wharton's jelly) atrophy of the optic nerves ophthalmology 2017 experimental therapy Poland 35,5
255 cord tissue (Wharton's jelly) epilepsia neurology 2017 experimental therapy Poland 16,4
256 cord tissue (Wharton's jelly) spinal cord injury orthopedics 2017 experimental therapy Poland b/d
257 cord tissue (Wharton's jelly) tetraparesis orthopedics 2017 experimental therapy Poland 27,11
258 cord tissue (Wharton's jelly) acute graft versus host disease hematology 2017 experimental therapy Poland 8,10
259 cord tissue (Wharton's jelly) epilepsia neurology 2017 experimental therapy Poland 9,11
260 cord tissue (Wharton's jelly) cerebral palsy neurology 2017 experimental therapy Poland 4,11
261 cord tissue (Wharton's jelly) cerebral palsy neurology 2017 experimental therapy Poland 15,3
262 cord tissue (Wharton's jelly) cerebral palsy; epilepsy neurology 2017 experimental therapy Poland 3,6
263 cord tissue (Wharton's jelly) cerebral palsy neurology 2017 experimental therapy Poland 13,6
264 cord tissue (Wharton's jelly) cerebral palsy neurology 2017 experimental therapy Poland 2,4
265 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2017 experimental therapy Poland 55,2
266 cord tissue (Wharton's jelly) sclerosis multiplex neurology 2017 experimental therapy Poland 53,10
267 cord tissue (Wharton's jelly) spinal cord injury orthopedics 2017 experimental therapy Poland b/d
268 cord tissue (Wharton's jelly) cerebral palsy neurology 2017 experimental therapy Poland 3,3
269 cord tissue (Wharton's jelly) cerebral palsy neurology 2017 experimental therapy Poland 2,3
270 cord tissue (Wharton's jelly) cerebral palsy neurology 2017 experimental therapy Poland 4,2
271 cord tissue (Wharton's jelly) spinal cord injury orthopedics 2017 experimental therapy Poland 27,3
272 cord tissue (Wharton's jelly) cerebral palsy neurology 2017 experimental therapy Poland 3,0
273 cord tissue (Wharton's jelly) cerebral palsy neurology 2017 experimental therapy Poland 4,9
274 cord tissue (Wharton's jelly) sclerosis multiplex neurology 2017 experimental therapy Poland 47,6
275 cord tissue (Wharton's jelly) retinitis pigmentosa ophthalmology 2017 experimental therapy Poland 65,4
276 cord tissue (Wharton's jelly) spina bifida neurology 2017 experimental therapy Poland 2,3
277 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2017 experimental therapy Poland 54,6
278 cord tissue (Wharton's jelly) optic atrophy ophthalmology 2017 experimental therapy Poland 77,5
279 cord tissue (Wharton's jelly) optic atrophy ophthalmology 2017 experimental therapy Poland 30,6
280 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2017 experimental therapy Poland 78,6
281 cord tissue (Wharton's jelly) spinal cord injury orthopedics 2017 experimental therapy Poland 33,8
282 cord tissue (Wharton's jelly) condition after myelitis neurology 2017 experimental therapy Poland 34,11
283 cord tissue (Wharton's jelly) retinitis pigmentosa ophthalmology 2017 experimental therapy Poland 43,11
284 cord tissue (Wharton's jelly) facio-scapulo-humeral muscular dystrophy neurology 2017 experimental therapy Poland 22,4
285 cord tissue (Wharton's jelly) muscular dystrophy neurology 2017 experimental therapy Poland 9,10
286 cord tissue (Wharton's jelly) delayed psychomotor development; epilepsia neurology 2017 experimental therapy Poland 11,8
287 cord tissue (Wharton's jelly) spina bifida neurology 2017 experimental therapy Poland 18,5
288 cord tissue (Wharton's jelly) cerebral palsy neurology 2017 experimental therapy Poland 7,8
289 cord tissue (Wharton's jelly) cerebral palsy neurology 2017 experimental therapy Poland 6,2
290 cord tissue (Wharton's jelly) cerebral palsy neurology 2017 experimental therapy Poland 10,0
291 cord tissue (Wharton's jelly) encephalopathy neurology 2017 experimental therapy Poland 1,6
292 cord tissue (Wharton's jelly) sclerosis multiplex neurology 2017 experimental therapy Poland 32,9
293 cord tissue (Wharton's jelly) cerebral palsy neurology 2017 experimental therapy Poland 4,6
294 cord tissue (Wharton's jelly) cerebral palsy neurology 2017 experimental therapy Poland 1,11
295 cord tissue (Wharton's jelly) retinitis pigmentosa ophthalmology 2017 experimental therapy Poland 22,10
296 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2017 experimental therapy Poland 44,0
297 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2017 experimental therapy Poland 78,7
298 cord tissue (Wharton's jelly) Stargardt's disease ophthalmology 2017 experimental therapy Poland 37,8
299 cord tissue (Wharton's jelly) spinal cord injury orthopedics 2017 experimental therapy Poland 3,4
300 cord tissue (Wharton's jelly) epilepsia neurology 2017 experimental therapy Poland 12,11
301 cord tissue (Wharton's jelly) retinitis pigmentosa ophthalmology 2017 experimental therapy Poland 61,3
302 cord tissue (Wharton's jelly) gonarthrosis orthopedics 2017 experimental therapy Poland 65,6
303 cord tissue (Wharton's jelly) hypoxia-ischemic encephalopathy neurology 2017 experimental therapy Poland 1,10
304 cord tissue (Wharton's jelly) tetraparesis spastica; epilepsia neurology 2017 experimental therapy Poland 2,8
305 cord tissue (Wharton's jelly) spina bifida neurology 2017 experimental therapy Poland 5,10
306 cord tissue (Wharton's jelly) spinal cord injury; tetraparesis orthopedics 2017 experimental therapy Poland 42,9
307 cord tissue (Wharton's jelly) cerebral palsy neurology 2017 experimental therapy Poland 4,2
308 cord tissue (Wharton's jelly) spina bifida neurology 2017 experimental therapy Poland 11,10
309 cord tissue (Wharton's jelly) cerebral palsy neurology 2017 experimental therapy Poland 24,8
310 cord tissue (Wharton's jelly) spinal cord injury orthopedics 2017 experimental therapy Poland 38,4
311 cord tissue (Wharton's jelly) muscular dystrophy neurology 2017 experimental therapy Poland 14,5
312 cord tissue (Wharton's jelly) cerebral palsy neurology 2017 experimental therapy Poland 8,1
313 cord tissue (Wharton's jelly) autism neurology 2017 experimental therapy Poland 12,2
314 cord tissue (Wharton's jelly) gonarthrosis orthopedics 2017 experimental therapy Poland 66,8
315 cord tissue (Wharton's jelly) optic atrophy ophthalmology 2017 experimental therapy Poland 85,7
316 cord tissue (Wharton's jelly) other specific disorders of the central nervous system neurology 2017 experimental therapy Poland 2,1
317 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2017 experimental therapy Poland 60,1
318 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2017 experimental therapy Poland 28,7
319 cord tissue (Wharton's jelly) cerebral palsy neurology 2017 experimental therapy Poland 1,6
320 cord tissue (Wharton's jelly) muscular dystrophy neurology 2017 experimental therapy Poland 8,0
321 cord tissue (Wharton's jelly) cerebellar syndrome neurology 2017 experimental therapy Poland 52,6
322 cord tissue (Wharton's jelly) spinocerebellar ataxia neurology 2017 experimental therapy Poland 35,9
323 cord tissue (Wharton's jelly) cerebellar syndrome neurology 2017 experimental therapy Poland 60,11
324 cord tissue (Wharton's jelly) congenital malformations of the nervous system, unspecified neurology 2017 experimental therapy Poland 8,2
325 cord tissue (Wharton's jelly) spina bifida neurology 2017 experimental therapy Poland 10,3
326 cord tissue (Wharton's jelly) cerebral palsy neurology 2017 experimental therapy Poland 2,8
327 cord tissue (Wharton's jelly) spinocerebellar ataxia neurology 2017 experimental therapy Poland 24,6
328 cord tissue (Wharton's jelly) muscular dystrophy neurology 2017 experimental therapy Poland 29,8
329 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2017 experimental therapy Poland 78,5
330 cord tissue (Wharton's jelly) retinitis pigmentosa ophthalmology 2017 experimental therapy Poland 61,7
331 cord tissue (Wharton's jelly) retinitis pigmentosa ophthalmology 2017 experimental therapy Poland 65,10
332 cord tissue (Wharton's jelly) cerebral palsy neurology 2017 experimental therapy Poland 10,9
333 cord tissue (Wharton's jelly) cerebral palsy neurology 2017 experimental therapy Poland 17,0
334 cord tissue (Wharton's jelly) cerebral palsy neurology 2017 experimental therapy Poland 5,6
335 cord tissue (Wharton's jelly) optic atrophy ophthalmology 2017 experimental therapy Poland 52,8
336 cord tissue (Wharton's jelly) cerebral palsy; epilepsy neurology 2017 experimental therapy Poland 2,1
337 cord tissue (Wharton's jelly) autism; encephalopathy neurology 2017 experimental therapy Poland 7,11
338 cord tissue (Wharton's jelly) cerebral palsy neurology 2017 experimental therapy Poland 5,9
339 cord tissue (Wharton's jelly) autism neurology 2017 experimental therapy Poland 5,10
340 cord tissue (Wharton's jelly) sclerosis multiplex neurology 2017 experimental therapy Poland 69,2
341 cord tissue (Wharton's jelly) sclerosis multiplex neurology 2017 experimental therapy Poland 64,3
342 cord tissue (Wharton's jelly) cartilage damage orthopedics 2017 experimental therapy Poland 46,10
343 cord tissue (Wharton's jelly) optic atrophy ophthalmology 2017 experimental therapy Poland 37,1
344 cord tissue (Wharton's jelly) retinitis pigmentosa ophthalmology 2017 experimental therapy Poland 43,10
345 cord tissue (Wharton's jelly) optic atrophy ophthalmology 2017 experimental therapy Poland 59,0
346 cord tissue (Wharton's jelly) cerebellar syndrome neurology 2017 experimental therapy Poland 46,5
347 cord tissue (Wharton's jelly) cerebral palsy neurology 2017 experimental therapy Poland 2,8
348 cord tissue (Wharton's jelly) autism neurology 2017 experimental therapy Poland 6,5
349 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2017 experimental therapy Poland 54,2
350 cord tissue (Wharton's jelly) other specific disorders of the central nervous system neurology 2017 experimental therapy Poland 2,4
351 cord tissue (Wharton's jelly) cerebral palsy neurology 2017 experimental therapy Poland 8,6
352 cord tissue (Wharton's jelly) muscular dystrophy neurology 2017 experimental therapy Poland 7,4
353 cord tissue (Wharton's jelly) cerebellar ataxia neurology 2017 experimental therapy Poland 33,0
354 cord tissue (Wharton's jelly) retinitis pigmentosa ophthalmology 2017 experimental therapy Poland 36,9
355 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2017 experimental therapy Poland 45,3
356 cord tissue (Wharton's jelly) cerebral palsy neurology 2017 experimental therapy Poland 6,2
357 cord tissue (Wharton's jelly) autism neurology 2017 experimental therapy Poland 7,8
358 cord tissue (Wharton's jelly) cerebral palsy neurology 2017 experimental therapy Poland 1,6
359 cord tissue (Wharton's jelly) acute graft versus host disease hematology 2017 experimental therapy Poland 7,6
360 cord tissue (Wharton's jelly) optic atrophy ophthalmology 2017 experimental therapy Poland 66,10
361 cord tissue (Wharton's jelly) retinitis pigmentosa ophthalmology 2017 experimental therapy Poland 48,8
362 cord tissue (Wharton's jelly) delayed psychomotor development neurology 2017 experimental therapy Poland 8,3
363 cord tissue (Wharton's jelly) epilepsia neurology 2017 experimental therapy Poland 15,9
364 cord tissue (Wharton's jelly) spinal cord injury orthopedics 2017 experimental therapy Poland 14,4
365 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2017 experimental therapy Poland 48,2
366 cord tissue (Wharton's jelly) cerebral palsy neurology 2017 experimental therapy Poland 2,5
367 cord tissue (Wharton's jelly) cerebral palsy neurology 2017 experimental therapy Poland 6,2
368 cord tissue (Wharton's jelly) optic neuropathy ophthalmology 2017 experimental therapy Poland 7,11
369 cord tissue (Wharton's jelly) spina bifida neurology 2017 experimental therapy Poland 9/12
370 cord tissue (Wharton's jelly) moyamoya disease neurology 2017 experimental therapy Poland 17,7
371 cord tissue (Wharton's jelly) anterior ischemic optic neuropathy ophthalmology 2017 experimental therapy Poland 67,7
372 cord tissue (Wharton's jelly) spinal cord injury orthopedics 2017 experimental therapy Poland 57,1
373 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2017 experimental therapy Poland 71,8
374 cord tissue (Wharton's jelly) cerebral palsy neurology 2016 experimental therapy Poland 10,11
375 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 44,5
376 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 60,8
377 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 32,2
378 cord tissue (Wharton's jelly) spinocerebellar ataxia neurology 2016 experimental therapy Poland 64
379 cord tissue (Wharton's jelly) spinocerebellar ataxia neurology 2016 experimental therapy Poland 62,5
380 cord tissue (Wharton's jelly) autism neurology 2016 experimental therapy Poland 18,4
381 cord tissue (Wharton's jelly) dystrophia progressiva pseudohypertrophica /DMD neurology 2016 experimental therapy Poland 48,8
382 cord tissue (Wharton's jelly) cerebral palsy neurology 2016 experimental therapy Poland 10,3
383 cord tissue (Wharton's jelly) facio-scapulo-humeral muscular dystrophy neurology 2016 experimental therapy Poland 35,3
384 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 53,7
385 cord tissue (Wharton's jelly) cerebral palsy neurology 2016 experimental therapy Poland 12,2
386 cord tissue (Wharton's jelly) delayed psychomotor development neurology 2016 experimental therapy Poland 3,10
387 cord tissue (Wharton's jelly) acute graft versus host disease hematology 2016 experimental therapy Poland 14
388 cord tissue (Wharton's jelly) acute graft versus host disease hematology 2016 experimental therapy Poland 6
389 cord tissue (Wharton's jelly) gonarthrosis orthopedics 2016 experimental therapy Poland 65,8
390 cord tissue (Wharton's jelly) leukodystrophy neurology 2016 experimental therapy Poland 2,9
391 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 59,4
392 cord tissue (Wharton's jelly) autism neurology 2016 experimental therapy Poland 6
393 cord tissue (Wharton's jelly) cerebral palsy neurology 2016 experimental therapy Poland 2,11
394 cord tissue (Wharton's jelly) autism neurology 2016 experimental therapy Poland 12,11
395 cord tissue (Wharton's jelly) cerebral palsy neurology 2016 experimental therapy Poland 9,7
396 cord tissue (Wharton's jelly) atrophy of the optic nerves ophthalmology 2016 experimental therapy Poland 20,3
397 cord tissue (Wharton's jelly) Stargardt's disease ophthalmology 2016 experimental therapy Poland 53
398 cord tissue (Wharton's jelly) spinal cord injury orthopedics 2016 experimental therapy Poland 33,5
399 cord tissue (Wharton's jelly) spinal cord injury orthopedics 2016 experimental therapy Poland 22,2
400 cord tissue (Wharton's jelly) cerebral palsy neurology 2016 experimental therapy Poland 10,3
401 cord tissue (Wharton's jelly) autism neurology 2016 experimental therapy Poland 8,5
402 cord tissue (Wharton's jelly) sclerosis multiplex neurology 2016 experimental therapy Poland 29,11
403 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 33,4
404 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 37,4
405 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 39,3
406 cord tissue (Wharton's jelly) autism neurology 2016 experimental therapy Poland 7,11
407 cord tissue (Wharton's jelly) spinal cord injury orthopedics 2016 experimental therapy Poland 28
408 cord tissue (Wharton's jelly) gonarthrosis orthopedics 2016 experimental therapy Poland 69,6
409 cord tissue (Wharton's jelly) spinal cord injury orthopedics 2016 experimental therapy Poland 33,11
410 cord tissue (Wharton's jelly) spinal cord injury orthopedics 2016 experimental therapy Poland 20,7
411 cord tissue (Wharton's jelly) spinal cord injury orthopedics 2016 experimental therapy Poland 24,5
412 cord tissue (Wharton's jelly) spinal cord injury orthopedics 2016 experimental therapy Poland 25,6
413 cord tissue (Wharton's jelly) autism neurology 2016 experimental therapy Poland 8,5
414 cord tissue (Wharton's jelly) facio-scapulo-humeral muscular dystrophy neurology 2016 experimental therapy Poland 39,10
415 cord tissue (Wharton's jelly) patella cartilage damage orthopedics 2016 experimental therapy Poland 60,10
416 cord tissue (Wharton's jelly) autism neurology 2016 experimental therapy Poland 6,9
417 cord tissue (Wharton's jelly) sclerosis multiplex neurology 2016 experimental therapy Poland 44,8
418 cord tissue (Wharton's jelly) facio-scapulo-humeral muscular dystrophy neurology 2016 experimental therapy Poland 25,4
419 cord tissue (Wharton's jelly) autism neurology 2016 experimental therapy Poland 10,10
420 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 63,2
421 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 54,11
422 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 53,9
423 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 46,9
424 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 58
425 cord tissue (Wharton's jelly) chronic graft versus host disease hematology 2016 experimental therapy Poland 19,2
426 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 55
427 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 58,1
428 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 61,7
429 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 52,6
430 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 59,11
431 cord tissue (Wharton's jelly) tetraparesis spastica orthopedics 2016 experimental therapy Poland 28,8
432 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 60,9
433 cord tissue (Wharton's jelly) spinal muscular atrophy neurology 2016 experimental therapy Poland 34,9
434 cord tissue (Wharton's jelly) gonarthrosis orthopedics 2016 experimental therapy Poland 69,3
435 cord tissue (Wharton's jelly) tetraparesis spastica orthopedics 2016 experimental therapy Poland 47,9
436 cord tissue (Wharton's jelly) spinal cord injury orthopedics 2016 experimental therapy Poland 18,8
437 cord tissue (Wharton's jelly) cerebral palsy neurology 2016 experimental therapy Poland 2,9
438 cord tissue (Wharton's jelly) traumatic brain injury neurology 2016 experimental therapy Poland 54,9
439 cord tissue (Wharton's jelly) epilepsia neurology 2016 experimental therapy Poland 19,5
440 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 59
441 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 66,9
442 cord tissue (Wharton's jelly) tetraparesis orthopedics 2016 experimental therapy Poland 27,9
443 cord tissue (Wharton's jelly) epilepsia neurology 2016 experimental therapy Poland 14,9
444 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 42,7
445 cord tissue (Wharton's jelly) acute graft versus host disease hematology 2016 experimental therapy Poland 60,5
446 cord tissue (Wharton's jelly) autism neurology 2016 experimental therapy Poland 6,2
447 cord tissue (Wharton's jelly) autism neurology 2016 experimental therapy Poland 11,3
448 cord tissue (Wharton's jelly) cerebral palsy neurology 2016 experimental therapy Poland 9,11
449 cord tissue (Wharton's jelly) gonarthrosis orthopedics 2016 experimental therapy Poland 49,8
450 cord tissue (Wharton's jelly) optic atrophy ophthalmology 2016 experimental therapy Poland 69,9
451 cord tissue (Wharton's jelly) optic atrophy ophthalmology 2016 experimental therapy Poland 69,1
452 cord tissue (Wharton's jelly) epilepsia neurology 2016 experimental therapy Poland 13,11
453 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 45
454 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 53
455 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 36
456 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 59, 1
457 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 66
458 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 50
459 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 55
460 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 46
461 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 72
462 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 54
463 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 56
464 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 62
465 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 65
466 cord tissue (Wharton's jelly) malformation syndrome neurology 2016 experimental therapy Poland 3,5
467 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 64,2
468 cord tissue (Wharton's jelly) retinitis pigmentosa ophthalmology 2016 experimental therapy Poland 38
469 cord tissue (Wharton's jelly) autism neurology 2016 experimental therapy Poland 6,10
470 cord tissue (Wharton's jelly) encephalopathy neurology 2016 experimental therapy Poland 2,11
471 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 62,8
472 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 56,5
473 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 51,3
474 cord tissue (Wharton's jelly) cerebral palsy neurology 2016 experimental therapy Poland 4,2
475 cord tissue (Wharton's jelly) sclerosis multiplex neurology 2016 experimental therapy Poland 55,4
476 cord tissue (Wharton's jelly) sclerosis multiplex neurology 2016 experimental therapy Poland 54,8
477 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 33,10
478 cord tissue (Wharton's jelly) sclerosis multiplex neurology 2016 experimental therapy Poland 41,4
479 cord tissue (Wharton's jelly) sclerosis multiplex neurology 2016 experimental therapy Poland 49,3
480 cord tissue (Wharton's jelly) choroideremia ophthalmology 2016 experimental therapy Poland 50,8
481 cord tissue (Wharton's jelly) retinitis pigmentosa ophthalmology 2016 experimental therapy Poland 63,1
482 cord tissue (Wharton's jelly) spinal cord injury orthopedics 2016 experimental therapy Poland 7,4
483 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 60,4
484 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 73,7
485 cord tissue (Wharton's jelly) leukodystrophy neurology 2016 experimental therapy Poland 2,11
486 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 61,6
487 cord tissue (Wharton's jelly) spinal cord injury orthopedics 2016 experimental therapy Poland 48,3
488 cord tissue (Wharton's jelly) retinitis pigmentosa ophthalmology 2016 experimental therapy Poland 32,7
489 cord tissue (Wharton's jelly) acute graft versus host disease hematology 2016 experimental therapy Poland 3,11
490 cord tissue (Wharton's jelly) sclerosis multiplex neurology 2016 experimental therapy Poland 61,11
491 cord tissue (Wharton's jelly) sclerosis multiplex neurology 2016 experimental therapy Poland 45,8
492 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 61,4
493 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 79,2
494 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 72,6
495 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 48,4
496 cord tissue (Wharton's jelly) adrenoleukodystrophy neurology 2016 experimental therapy Poland 6,11
497 cord tissue (Wharton's jelly) adrenoleukodystrophy neurology 2016 experimental therapy Poland 9,7
498 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 54,2
499 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 50,9
500 cord tissue (Wharton's jelly) limb-girdle muscular dystrophy neurology 2016 experimental therapy Poland 22
501 cord tissue (Wharton's jelly) epilepsia neurology 2016 experimental therapy Poland 14,7
502 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 55,9
503 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 62,6
504 cord tissue (Wharton's jelly) spinal cord injury orthopedics 2016 experimental therapy Poland 58,10
505 cord tissue (Wharton's jelly) cerebral palsy neurology 2016 experimental therapy Poland 12,6
506 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 66,2
507 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 55,9
508 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 49,4
509 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 55,7
510 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 58
511 cord tissue (Wharton's jelly) spina bifida neurology 2016 experimental therapy Poland 5
512 cord tissue (Wharton's jelly) spina bifida neurology 2016 experimental therapy Poland 2
513 cord tissue (Wharton's jelly) cerebral palsy neurology 2016 experimental therapy Poland 3
514 cord tissue (Wharton's jelly) cerebral palsy neurology 2016 experimental therapy Poland 10
515 cord tissue (Wharton's jelly) global developmental delay neurology 2016 experimental therapy Poland 7
516 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 67
517 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 40
518 cord tissue (Wharton's jelly) autism neurology 2016 experimental therapy Poland 13
519 cord tissue (Wharton's jelly) developmental delay neurology 2016 experimental therapy Poland 7
520 cord tissue (Wharton's jelly) spina bifida neurology 2016 experimental therapy Poland 7
521 cord tissue (Wharton's jelly) optic neuropathy ophthalmology 2016 experimental therapy Poland 66
522 cord tissue (Wharton's jelly) sclerosis multiplex neurology 2016 experimental therapy Poland 38
523 cord tissue (Wharton's jelly) autism neurology 2016 experimental therapy Poland 8
524 cord tissue (Wharton's jelly) cerebral palsy neurology 2016 experimental therapy Poland 3
525 cord tissue (Wharton's jelly) optic neuropathy ophthalmology 2016 experimental therapy Poland 79,8
526 cord tissue (Wharton's jelly) spinocerebellar ataxia neurology 2016 experimental therapy Poland 54,3
527 cord tissue (Wharton's jelly) dystrophia progressiva pseudohypertrophica /DMD neurology 2016 experimental therapy Poland 14,4
528 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 47,11
529 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 49,3
530 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 61,2
531 cord tissue (Wharton's jelly) retinitis pigmentosa ophthalmology 2016 experimental therapy Poland 24
532 cord tissue (Wharton's jelly) age-related macular degeneration ophthalmology 2016 experimental therapy Poland 87
533 cord tissue (Wharton's jelly) retinitis pigmentosa ophthalmology 2016 experimental therapy Poland 55
534 cord tissue (Wharton's jelly) sclerosis multiplex neurology 2016 experimental therapy Poland 68,5
535 cord tissue (Wharton's jelly) cerebral palsy neurology 2016 experimental therapy Poland 13,7
536 cord tissue (Wharton's jelly) cerebral palsy neurology 2016 experimental therapy Poland 2,2
537 cord tissue (Wharton's jelly) autism neurology 2016 experimental therapy Poland 5,0
538 cord tissue (Wharton's jelly) cerebral palsy neurology 2016 experimental therapy Poland 12,11
539 cord tissue (Wharton's jelly) autism neurology 2016 experimental therapy Poland 12,3
540 cord tissue (Wharton's jelly) spina bifida neurology 2016 experimental therapy Poland 1,3
541 cord tissue (Wharton's jelly) developmental delay neurology 2016 experimental therapy Poland 2,7
542 cord tissue (Wharton's jelly) spinal muscular atrophy neurology 2016 experimental therapy Poland 3,3
543 cord tissue (Wharton's jelly) facio-scapulo-humeral muscular dystrophy neurology 2016 experimental therapy Poland 59,6
544 cord tissue (Wharton's jelly) spinal muscular atrophy neurology 2016 experimental therapy Poland 34,2
545 cord tissue (Wharton's jelly) muscular dystrophy neurology 2016 experimental therapy Poland 30,3
546 cord tissue (Wharton's jelly) spinal muscular atrophy neurology 2016 experimental therapy Poland 17,10
547 cord tissue (Wharton's jelly) spinal cord injury orthopedics 2016 experimental therapy Poland 37,11
548 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 31,9
549 cord tissue (Wharton's jelly) ataxia hereditaria neurology 2016 experimental therapy Poland 69
550 cord tissue (Wharton's jelly) muscular dystrophy neurology 2016 experimental therapy Poland 31,9
551 cord tissue (Wharton's jelly) no data ophthalmology 2016 experimental therapy Poland 66,1
552 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 53,4
553 cord tissue (Wharton's jelly) patella cartilage damage orthopedics 2016 experimental therapy Poland 60,8
554 cord tissue (Wharton's jelly) cerebral palsy neurology 2016 experimental therapy Poland 10,8
555 cord tissue (Wharton's jelly) encephalopathy neurology 2016 experimental therapy Poland 3
556 cord tissue (Wharton's jelly) spina bifida neurology 2016 experimental therapy Poland 2,11
557 cord tissue (Wharton's jelly) encephalopathy neurology 2016 experimental therapy Poland 4,3
558 cord tissue (Wharton's jelly) retinitis pigmentosa ophthalmology 2016 experimental therapy Poland no data
559 cord tissue (Wharton's jelly) retinitis pigmentosa ophthalmology 2016 experimental therapy Poland 59,4
560 cord tissue (Wharton's jelly) atrophy of the optic nerves ophthalmology 2016 experimental therapy Poland 20,11
561 cord tissue (Wharton's jelly) patella cartilage damage orthopedics 2016 experimental therapy Poland 53
562 cord tissue (Wharton's jelly) autism neurology 2016 experimental therapy Poland 24,5
563 cord tissue (Wharton's jelly) dystrophia progressiva pseudohypertrophica /DMD neurology 2016 experimental therapy Poland 34, 7
564 cord tissue (Wharton's jelly) muscular dystrophy neurology 2016 experimental therapy Poland 32,3
565 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 65,9
566 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 52,7
567 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 71,5
568 cord tissue (Wharton's jelly) retinitis pigmentosa ophthalmology 2016 experimental therapy Poland 60,7
569 cord tissue (Wharton's jelly) cerebral palsy neurology 2016 experimental therapy Poland 1,10
570 cord tissue (Wharton's jelly) cerebral palsy neurology 2016 experimental therapy Poland 7,6
571 cord tissue (Wharton's jelly) spinal muscular atrophy neurology 2016 experimental therapy Poland 1,10
572 cord tissue (Wharton's jelly) spinal cord injury orthopedics 2016 experimental therapy Poland 29,7
573 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 68,5
574 cord tissue (Wharton's jelly) chronic graft versus host disease hematology 2016 experimental therapy Poland 8/12
575 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 44,5
576 cord tissue (Wharton's jelly) dystrophia progressiva pseudohypertrophica /DMD neurology 2016 experimental therapy Poland 9,2
577 cord tissue (Wharton's jelly) Stargardt's disease ophthalmology 2016 experimental therapy Poland 24,5
578 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 66,7
579 cord tissue (Wharton's jelly) spina bifida neurology 2016 experimental therapy Poland 15,9
580 cord tissue (Wharton's jelly) cerebral palsy neurology 2016 experimental therapy Poland 6,8
581 cord tissue (Wharton's jelly) autism neurology 2016 experimental therapy Poland 10,3
582 cord tissue (Wharton's jelly) cerebral palsy neurology 2016 experimental therapy Poland 16,4
583 cord tissue (Wharton's jelly) autism neurology 2016 experimental therapy Poland 6
584 cord tissue (Wharton's jelly) spinocerebellar ataxia neurology 2016 experimental therapy Poland 41,8
585 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 51,9
586 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 49,3
587 cord tissue (Wharton's jelly) autism neurology 2016 experimental therapy Poland 20,9
588 cord tissue (Wharton's jelly) fetal alcohol spectrum disorders neurology 2016 experimental therapy Poland 5,2
589 cord tissue (Wharton's jelly) cerebral palsy neurology 2016 experimental therapy Poland 13,10
590 cord tissue (Wharton's jelly) tetraparesis spastica orthopedics 2016 experimental therapy Poland 58,4
591 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 68,2
592 cord tissue (Wharton's jelly) chondronecrosis femoral condyle orthopedics 2016 experimental therapy Poland 54,11
593 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 55
594 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 41
595 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 72
596 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 57
597 cord tissue (Wharton's jelly) spina bifida neurology 2016 experimental therapy Poland 2
598 cord tissue (Wharton's jelly) tetraparesis spastica orthopedics 2016 experimental therapy Poland 18
599 cord tissue (Wharton's jelly) cerebral palsy neurology 2016 experimental therapy Poland 4,1
600 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 48,1
601 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 56,3
602 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 66,10
603 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland no data
604 cord tissue (Wharton's jelly) gangliosidosis t. 1 neurology 2016 experimental therapy Poland 1,4
605 cord tissue (Wharton's jelly) epilepsia neurology 2016 experimental therapy Poland 15
606 cord tissue (Wharton's jelly) epileptic encephalopathy neurology 2016 experimental therapy Poland 4
607 cord tissue (Wharton's jelly) polineuropathy neurology 2016 experimental therapy Poland 71
608 cord tissue (Wharton's jelly) diffuse cartilage damage left medial compartment of the knee orthopedics 2016 experimental therapy Poland 50,5
609 cord tissue (Wharton's jelly) Stargardt's disease ophthalmology 2016 experimental therapy Poland 37,7
610 cord tissue (Wharton's jelly) myopia, hyperopia, astigmatism, abnormal refraction and accommodation, optic atrophy ophthalmology 2016 experimental therapy Poland 37,1
611 cord tissue (Wharton's jelly) optic neuropathy ophthalmology 2016 experimental therapy Poland 33,5
612 cord tissue (Wharton's jelly) epilepsia neurology 2016 experimental therapy Poland 16,2
613 cord tissue (Wharton's jelly) cerebral palsy neurology 2016 experimental therapy Poland 3,7
614 cord tissue (Wharton's jelly) spinal cord injury orthopedics 2016 experimental therapy Poland 17,9
615 cord tissue (Wharton's jelly) injuries to the spinal nerves neurology 2016 experimental therapy Poland 5/12
616 cord tissue (Wharton's jelly) cartilage damage orthopedics 2016 experimental therapy Poland 57,6
617 cord tissue (Wharton's jelly) dystrophia progressiva pseudohypertrophica /DMD neurology 2016 experimental therapy Poland 4,8
618 cord tissue (Wharton's jelly) muscular dystrophy neurology 2016 experimental therapy Poland 44,7
619 cord tissue (Wharton's jelly) dystrophia progressiva pseudohypertrophica /DMD neurology 2016 experimental therapy Poland 10
620 cord tissue (Wharton's jelly) cerebral palsy neurology 2016 experimental therapy Poland 4,4
621 cord tissue (Wharton's jelly) spina bifida neurology 2016 experimental therapy Poland 4,9
622 cord tissue (Wharton's jelly) cerebellar syndrome neurology 2016 experimental therapy Poland 28,6
623 cord tissue (Wharton's jelly) neurodevelopmental disorders neurology 2016 experimental therapy Poland 4,5
624 cord tissue (Wharton's jelly) tetraparesis orthopedics 2016 experimental therapy Poland 27,2
625 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 61,2
626 cord tissue (Wharton's jelly) retinitis pigmentosa ophthalmology 2016 experimental therapy Poland 44,8
627 cord tissue (Wharton's jelly) degeneration of the cartilage of the knee joint orthopedics 2016 experimental therapy Poland 54,3
628 cord tissue (Wharton's jelly) dystrophia progressiva pseudohypertrophica /BMD neurology 2016 experimental therapy Poland 19,2
629 cord tissue (Wharton's jelly) facio-scapulo-humeral muscular dystrophy neurology 2016 experimental therapy Poland 15,0
630 cord tissue (Wharton's jelly) facio-scapulo-humeral muscular dystrophy neurology 2016 experimental therapy Poland 31,11
631 cord tissue (Wharton's jelly) facio-scapulo-humeral muscular dystrophy neurology 2016 experimental therapy Poland 33,4
632 cord tissue (Wharton's jelly) endometrial atrophy ginecology 2016 experimental therapy Poland 37,3
633 cord tissue (Wharton's jelly) endometrial atrophy ginecology 2016 experimental therapy Poland 39,1
634 cord tissue (Wharton's jelly) sclerosis multiplex neurology 2016 experimental therapy Poland 38,4
635 cord tissue (Wharton's jelly) spinal cord injury orthopedics 2016 experimental therapy Poland 44,5
636 cord tissue (Wharton's jelly) meniscus damage orthopedics 2016 experimental therapy Poland 35,5
637 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 60,8
638 cord tissue (Wharton's jelly) premature ovarian failure ginecology 2016 experimental therapy Poland 23,4
639 cord tissue (Wharton's jelly) premature ovarian failure ginecology 2016 experimental therapy Poland 34,9
640 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 55,5
641 cord tissue (Wharton's jelly) acute graft versus host disease hematology 2015 experimental therapy Poland 1,4
642 cord tissue (Wharton's jelly) autism neurology 2015 experimental therapy Poland 5,4
643 cord tissue (Wharton's jelly) sclerosis multiplex neurology 2015 experimental therapy Poland 23,2
644 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2015 experimental therapy Poland 61,6
645 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2015 experimental therapy Poland 61
646 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2015 experimental therapy Poland 56
647 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2015 experimental therapy Poland 51
648 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2015 experimental therapy Poland 65
649 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2015 experimental therapy Poland 60
650 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2015 experimental therapy Poland 52
651 cord tissue (Wharton's jelly) cerebral palsy neurology 2015 experimental therapy Poland 3,8
652 cord tissue (Wharton's jelly) decerebration rigidity neurology 2015 experimental therapy Poland 9,6
653 cord tissue (Wharton's jelly) bilateral blindness ophthalmology 2015 experimental therapy Poland 36,10
654 cord tissue (Wharton's jelly) acute graft versus host disease hematology 2015 experimental therapy Poland 11/12
655 cord tissue (Wharton's jelly) cerebral palsy neurology 2015 experimental therapy Poland 7,1
656 cord tissue (Wharton's jelly) cerebral palsy neurology 2015 experimental therapy Poland 15,8
657 cord tissue (Wharton's jelly) ceroid lipofuscinosis neurology 2015 experimental therapy Poland 5,1
658 cord tissue (Wharton's jelly) encephalopathy neurology 2015 experimental therapy Poland 14,5
659 cord tissue (Wharton's jelly) ceroid lipofuscinosis neurology 2015 experimental therapy Poland 7,10
660 cord tissue (Wharton's jelly) autism neurology 2015 experimental therapy Poland 3
661 cord tissue (Wharton's jelly) cerebral palsy neurology 2015 experimental therapy Poland 7,1
662 cord tissue (Wharton's jelly) cerebral palsy neurology 2015 experimental therapy Poland 13,1
663 cord tissue (Wharton's jelly) spina bifida neurology 2015 experimental therapy Poland 2,4
664 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2015 experimental therapy Poland 59,4
665 cord tissue (Wharton's jelly) spinal cord injury orthopedics 2015 experimental therapy Poland 31,2
666 cord tissue (Wharton's jelly) cerebral palsy neurology 2015 experimental therapy Poland 5,1
667 cord tissue (Wharton's jelly) autism neurology 2015 experimental therapy Poland 12,5
668 cord tissue (Wharton's jelly) cerebral palsy neurology 2015 experimental therapy Poland 8,11
669 cord tissue (Wharton's jelly) delayed psychomotor development, deafness neurology 2015 experimental therapy Poland 3,3
670 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2015 experimental therapy Poland 61,5
671 cord tissue (Wharton's jelly) traumatic encephalopathy neurology 2015 experimental therapy Poland 20,11
672 cord tissue (Wharton's jelly) spinal cord injury orthopedics 2015 experimental therapy Poland 18,8
673 cord tissue (Wharton's jelly) cerebral palsy neurology 2015 experimental therapy Poland 2,7
674 cord tissue (Wharton's jelly) adrenoleukodystrophy; encephalopathy neurology 2015 experimental therapy Poland 23
675 cord tissue (Wharton's jelly) adrenoleukodystrophy neurology 2015 experimental therapy Poland 11,11
676 cord tissue (Wharton's jelly) spinal cord injury orthopedics 2015 experimental therapy Poland 40
677 cord tissue (Wharton's jelly) spinal cord injury orthopedics 2015 experimental therapy Poland 26,1
678 cord tissue (Wharton's jelly) spinal cord injury orthopedics 2015 experimental therapy Poland 37,1
679 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2015 experimental therapy Poland 58
680 cord tissue (Wharton's jelly) spinocerebellar ataxia neurology 2015 experimental therapy Poland 35,6
681 cord tissue (Wharton's jelly) spinal muscular atrophy neurology 2015 experimental therapy Poland 11/12
682 cord tissue (Wharton's jelly) spinocerebellar ataxia neurology 2015 experimental therapy Poland 44,6
683 cord tissue (Wharton's jelly) optic neuropathy ophthalmology 2015 experimental therapy Poland 15,8
684 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2015 experimental therapy Poland 61,6
685 cord tissue (Wharton's jelly) gonarthrosis orthopedics 2015 experimental therapy Poland 66,2
686 cord tissue (Wharton's jelly) iatrogenic spinal cord injury neurology 2015 experimental therapy Poland 17,2
687 cord tissue (Wharton's jelly) optic neuropathy ophthalmology 2015 experimental therapy Poland 45,10
688 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2015 experimental therapy Poland 62
689 cord tissue (Wharton's jelly) acute graft versus host disease hematology 2015 experimental therapy Poland 51,5
690 cord tissue (Wharton's jelly) cerebral palsy neurology 2015 experimental therapy Poland 12,10
691 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2015 experimental therapy Poland 26,5
692 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2015 experimental therapy Poland 27
693 cord tissue (Wharton's jelly) cerebral palsy neurology 2015 experimental therapy Poland 4,10
694 cord tissue (Wharton's jelly) autism neurology 2015 experimental therapy Poland 6,1
695 cord tissue (Wharton's jelly) autism neurology 2015 experimental therapy Poland 4,6
696 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2015 experimental therapy Poland 63,11
697 cord tissue (Wharton's jelly) spinal cord injury orthopedics 2015 experimental therapy Poland 32,10
698 cord tissue (Wharton's jelly) cerebral palsy neurology 2015 experimental therapy Poland 22
699 cord tissue (Wharton's jelly) sclerosis multiplex neurology 2015 experimental therapy Poland 33,3
700 cord tissue (Wharton's jelly) delayed psychomotor development neurology 2015 experimental therapy Poland 3,6
701 cord tissue (Wharton's jelly) spina bifida neurology 2015 experimental therapy Poland 2
702 cord tissue (Wharton's jelly) cerebellar ataxia neurology 2015 experimental therapy Poland 18,7
703 cord tissue (Wharton's jelly) spinocerebellar ataxia neurology 2015 experimental therapy Poland 24,3
704 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2015 experimental therapy Poland 67,6
705 cord tissue (Wharton's jelly) autism neurology 2015 experimental therapy Poland 5,6
706 cord tissue (Wharton's jelly) polineuropathy neurology 2015 experimental therapy Poland 74,2
707 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2015 experimental therapy Poland 37,6
708 cord tissue (Wharton's jelly) stroke neurology 2015 experimental therapy Poland 62,8
709 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2015 experimental therapy Poland 58,10
710 cord tissue (Wharton's jelly) facio-scapulo-humeral muscular dystrophy neurology 2015 experimental therapy Poland 30,1
711 cord tissue (Wharton's jelly) chronic graft versus host disease hematology 2015 experimental therapy Poland 10
712 cord tissue (Wharton's jelly) severe developmental delay neurology 2015 experimental therapy Poland 1,1
713 cord tissue (Wharton's jelly) spinal muscular atrophy neurology 2015 experimental therapy Poland 26,2
714 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2015 experimental therapy Poland 46,2
715 cord tissue (Wharton's jelly) autism neurology 2015 experimental therapy Poland 8,7
716 cord tissue (Wharton's jelly) encephalopathy neurology 2015 experimental therapy Poland 8/12
717 cord tissue (Wharton's jelly) acute graft versus host disease hematology 2015 experimental therapy Poland 6,6
718 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2015 experimental therapy Poland 48,7
719 cord tissue (Wharton's jelly) spinal cord injury orthopedics 2015 experimental therapy Poland 21,4
720 cord tissue (Wharton's jelly) cerebral palsy neurology 2015 experimental therapy Poland 9,9
721 cord tissue (Wharton's jelly) acute graft versus host disease hematology 2015 experimental therapy Poland 13,4
722 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2015 experimental therapy Poland 61,3
723 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2015 experimental therapy Poland 54
724 cord tissue (Wharton's jelly) intracranial injury neurology 2015 experimental therapy Poland 24,3
725 cord tissue (Wharton's jelly) stroke neurology 2015 experimental therapy Poland 54,9
726 cord tissue (Wharton's jelly) spinal cord injury orthopedics 2015 experimental therapy Poland 24,7
727 cord tissue (Wharton's jelly) gonarthrosis orthopedics 2015 experimental therapy Poland 65,9
728 cord tissue (Wharton's jelly) leukodystrophy neurology 2015 experimental therapy Poland 18,8
729 cord tissue (Wharton's jelly) spinal cord injury orthopedics 2015 experimental therapy Poland 34,4
730 cord tissue (Wharton's jelly) cerebral palsy neurology 2015 experimental therapy Poland 1,6
731 cord tissue (Wharton's jelly) cerebral palsy neurology 2015 experimental therapy Poland 14,10
732 cord tissue (Wharton's jelly) anterior ischemic optic neuropathy ophthalmology 2015 experimental therapy Poland 54,10
733 cord tissue (Wharton's jelly) cerebral palsy neurology 2015 experimental therapy Poland 16,9
734 cord tissue (Wharton's jelly) retinitis pigmentosa ophthalmology 2015 experimental therapy Poland 34,5
735 cord tissue (Wharton's jelly) cerebellar ataxia neurology 2015 experimental therapy Poland 26,1
736 cord tissue (Wharton's jelly) encephalopathy neurology 2015 experimental therapy Poland 11,2
737 cord tissue (Wharton's jelly) adrenoleukodystrophy; encephalopathy neurology 2015 experimental therapy Poland 8,4
738 cord tissue (Wharton's jelly) neuropathy neurology 2014 experimental therapy Poland 24
739 cord tissue (Wharton's jelly) autism neurology 2014 experimental therapy Poland 12,6
740 cord tissue (Wharton's jelly) acute graft versus host disease hematology 2014 experimental therapy Poland 6
741 cord tissue (Wharton's jelly) central motor coordination impairment after hypoxic ischaemia lesion at birth neurology 2014 experimental therapy Poland 2,1
742 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2014 experimental therapy Poland 60,10
743 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2014 experimental therapy Poland 24,1
744 cord tissue (Wharton's jelly) autism neurology 2014 experimental therapy Poland 8,3
745 cord tissue (Wharton's jelly) muscular dystrophy neurology 2014 experimental therapy Poland 6
746 cord tissue (Wharton's jelly) birth asphyxia; retinopathy neurology 2014 experimental therapy Poland 11/12
747 cord tissue (Wharton's jelly) cerebral palsy neurology 2014 experimental therapy Poland 4,10
748 cord tissue (Wharton's jelly) cerebral palsy neurology 2014 experimental therapy Poland 15,10
749 cord tissue (Wharton's jelly) acute graft versus host disease hematology 2013 experimental therapy Poland 19
750 cord tissue (Wharton's jelly) acute graft versus host disease hematology 2013 experimental therapy Poland 2
751 cord tissue (Wharton's jelly) acute graft versus host disease hematology 2013 experimental therapy Poland 4
752 cord tissue (Wharton's jelly) acute myeloid leukemia hematology 2013 experimental therapy Poland 4
753 cord tissue (Wharton's jelly) chronic graft versus host disease hematology 2013 experimental therapy Poland 19
754 cord tissue (Wharton's jelly) chronic graft versus host disease hematology 2013 experimental therapy Poland 18
755 cord tissue (Wharton's jelly) acute graft versus host disease hematology 2012 experimental therapy Poland 20
756 cord tissue (Wharton's jelly) acute graft versus host disease hematology 2012 experimental therapy Poland 7
757 cord tissue (Wharton's jelly) acute graft versus host disease hematology 2012 experimental therapy Poland 4
758 cord tissue (Wharton's jelly) acute graft versus host disease hematology 2011 experimental therapy Poland 17
759 bone marrow other combined immunodeficiency hematology 2017 standard therapy USA 11
760 bone marrow acute lymphoblastic leukemia hematology 2017 standard therapy Italy 2
761 bone marrow severe combined immunodeficiency hematology 2016 standard therapy Poland 1
762 bone marrow severe aplastic anaemia hematology 2016 standard therapy France 9
763 bone marrow severe aplastic anaemia / paroxymal nocturnal haemoglobinuria hematology 2016 standard therapy Poland 17
764 bone marrow myelodysplastic syndrome hematology 2016 standard therapy Hungary 1
765 bone marrow acute myelogenous leukemia hematology 2016 standard therapy Italy 67
766 bone marrow myelodysplastic syndrome hematology 2016 standard therapy Spain 56
767 bone marrow Fanconi anaemia hematology 2016 standard therapy Netherlands 41
768 bone marrow acute myelogenous leukemia hematology 2017 standard therapy France 12
769 bone marrow myelodysplastic syndrome hematology 2017 standard therapy Norway 2
770 bone marrow Nijmegen breakage syndrome hematology 2017 standard therapy Poland 8
771 bone marrow acute lymphoblastic leukemia hematology 2016 standard therapy France 5
772 bone marrow acute myelogenous leukemia hematology 2016 standard therapy United Kingdom 29
773 bone marrow acute lymphoblastic leukemia hematology 2016 standard therapy Belarus 25
774 bone marrow acute lymphoblastic leukemia hematology 2016 standard therapy New Zealand 1
775 bone marrow severe combined immunodeficiency hematology 2016 standard therapy Germany 12
776 bone marrow acute lymphoblastic leukemia hematology 2016 standard therapy Poland 5
777 bone marrow secondary acute myelogenous leukemia after Ewing sarcoma hematology 2017 standard therapy Germany 16
778 bone marrow acute lymphoblastic leukemia hematology 2017 standard therapy India 7
779 bone marrow acute lymphoblastic leukemia hematology 2017 standard therapy USA 18
780 bone marrow acute myelogenous leukemia hematology 2017 standard therapy France 2
781 bone marrow  severe combined immunodeficiency hematology 2017 standard therapy Turkey 8
782 bone marrow no data n/a 2016 standard therapy Poland 33
783 bone marrow non-Hodgkin lymphoma hematology 2016 standard therapy Italy 46
784 bone marrow aplastic anaemia hematology 2016 standard therapy Austria 20
785 bone marrow acute myelogenous leukemia hematology 2016 standard therapy Croatia 33
786 bone marrow myeloproliferative syndrome hematology 2016 standard therapy Poland 22
787 bone marrow thalassemia major hematology 2017 standard therapy Turkey 11
788 bone marrow acute myelogenous leukemia hematology 2017 standard therapy Italy 10
789 bone marrow acute myelogenous leukemia hematology 2017 standard therapy Czech Republic 68
790 bone marrow acute myelogenous leukemia hematology 2017 standard therapy USA 60
791 bone marrow Fanconi anaemia hematology 2017 standard therapy Russia 10
792 bone marrow acute myelogenous leukemia hematology 2017 standard therapy USA 10
793 bone marrow acute myelogenous leukemia hematology 2017 standard therapy USA 17
794 bone marrow biphenotypic leukemia hematology 2016 standard therapy Brazil 27
795 bone marrow acute lymphoblastic leukemia hematology 2016 standard therapy Germany 7
796 bone marrow osteopetrosis metabolic 2016 standard therapy Germany 1
797 bone marrow acute myelogenous leukemia hematology 2017 standard therapy Italy 55
798 bone marrow acute myelogenous leukemia hematology 2017 standard therapy USA 67
799 bone marrow acute lymphoblastic leukemia hematology 2017 standard therapy Poland 16
800 bone marrow  severe combined immunodeficiency hematology 2017 standard therapy Lithuania 1
801 bone marrow acute myelogenous leukemia hematology 2017 standard therapy Italy 13
802 bone marrow acute lymphoblastic leukemia hematology 2017 standard therapy Italy 38
803 bone marrow acute lymphoblastic leukemia hematology 2017 standard therapy United Kingdom 9
804 bone marrow  severe combined immunodeficiency hematology 2017 standard therapy Canada 1
805 bone marrow no data n/a 2016 standard therapy Italy 3
806 bone marrow acute myelogenous leukemia hematology 2016 standard therapy Italy 64
807 bone marrow acute lymphoblastic leukemia hematology 2016 standard therapy Italy 9
808 bone marrow acute myelogenous leukemia hematology 2016 standard therapy Spain 55
809 bone marrow Fanconi anaemia hematology 2016 standard therapy Estonia 7
810 bone marrow acute myelogenous leukemia hematology 2017 standard therapy USA 51
811 bone marrow juvenile myelomonocytic leukemia hematology 2017 standard therapy Finland 1
812 bone marrow acute megakaryocytic leukemia hematology 2017 standard therapy Spain 2
813 bone marrow chronic myeloid leukemia hematology 2017 standard therapy USA 51
814 bone marrow acute myelogenous leukemia hematology 2017 standard therapy Italy 56
815 bone marrow acute myelogenous leukemia hematology 2017 standard therapy Russia 54
816 bone marrow acute myelogenous leukemia hematology 2017 standard therapy France 24
817 bone marrow  severe combined immunodeficiency hematology 2017 standard therapy Poland 1
818 bone marrow acute lymphoblastic leukemia hematology 2017 standard therapy United Kingdom 8
819 bone marrow severe aplastic anaemia hematology 2016 standard therapy France 9
820 bone marrow no data n/a 2016 standard therapy Poland 7
821 bone marrow Hurler syndrome metabolic 2016 standard therapy United Kingdom 2
822 bone marrow acute myelogenous leukemia hematology 2017 standard therapy Italy 9
823 bone marrow no data hematology 2017 standard therapy France 32
824 bone marrow acute lymphoblastic leukemia hematology 2017 standard therapy Brazil 14
825 bone marrow  severe combined immunodeficiency hematology 2016 standard therapy Turkey 4
826 bone marrow acute lymphoblastic leukemia hematology 2016 standard therapy Canada 11
827 bone marrow acute lymphoblastic leukemia hematology 2017 standard therapy Poland 6
828 bone marrow acute myelogenous leukemia hematology 2017 standard therapy Germany 76
829 bone marrow acute myelogenous leukemia hematology 2017 standard therapy Turkey 22
830 bone marrow chronic granulomatous disease hematology 2017 standard therapy Poland 2
831 bone marrow acute myelogenous leukemia hematology 2017 standard therapy Germany 65
832 bone marrow myelodysplastic syndrome hematology 2017 standard therapy Italy 60
833 bone marrow myelodysplastic syndrome hematology 2017 standard therapy USA 61
834 bone marrow osteopetrosis metabolic 2016 standard therapy Russia 6
835 bone marrow severe combined immunodeficiency hematology 2016 standard therapy Romania 2
836 bone marrow acute lymphoblastic leukemia hematology 2017 standard therapy Russia 30
837 bone marrow chronic granulomatous disease hematology 2017 standard therapy Poland 4
838 bone marrow leukemia hematology 2017 standard therapy USA 40
839 bone marrow acute lymphoblastic leukemia hematology 2017 standard therapy United Kingdom 10
840 bone marrow acute lymphoblastic leukemia hematology 2017 standard therapy Hungary 14
841 bone marrow severe combined immunodeficiency hematology 2017 standard therapy Turkey 6
842 bone marrow T-cell acute lymphoblastic leukemia hematology 2016 standard therapy Italy 4
843 bone marrow Fanconi anaemia hematology 2017 standard therapy Belarus 10
844 bone marrow acute lymphoblastic leukemia hematology 2017 standard therapy Hungary 7
845 bone marrow acute myelogenous leukemia hematology 2017 standard therapy USA 19
846 bone marrow primary Immunodeficiency; Nijmegen breakage syndrome hematology 2017 standard therapy Belarus 6
847 bone marrow acute myelogenous leukemia hematology 2016 standard therapy Ireland 39
848 bone marrow Diamond-Balckfan anaemia hematology 2016 standard therapy Germany 2
849 bone marrow acute myelogenous leukemia hematology 2016 standard therapy Czech Republic 9
850 bone marrow acute lymphoblastic leukemia hematology 2016 standard therapy Belarus 15
851 bone marrow juvenile myelomonocytic leukemia hematology 2016 standard therapy Germany 3
852 bone marrow acute myelogenous leukemia hematology 2016 standard therapy Finland 45
853 bone marrow anaemia hematology 2016 standard therapy Germany 16
854 bone marrow acute lymphoblastic leukemia hematology 2016 standard therapy Germany 6
855 bone marrow anaemia hematology 2016 standard therapy Italy 5
856 bone marrow high-risk acute lymphoblastic leukemia hematology 2016 standard therapy Poland 18
857 bone marrow acute lymphoblastic leukemia hematology 2017 standard therapy Italy 4
858 bone marrow Wiskott-Aldrich syndrome hematology 2017 standard therapy Iran 2
859 bone marrow T-cell leukemia/lymphoma hematology 2017 standard therapy Iran 18
860 bone marrow acute lymphoblastic leukemia hematology 2017 standard therapy Italy 7
861 bone marrow myeloma multiplex hematology 2017 standard therapy Canada 50
862 bone marrow myelofibrosis hematology 2016 standard therapy Germany 31
863 bone marrow DiGeorge syndrome hematology 2016 standard therapy Netherlands 24
864 bone marrow Hodgkin’s lymphoma hematology 2016 standard therapy Italy 17
865 bone marrow acute myelogenous leukemia hematology 2016 standard therapy Belarus 12
866 bone marrow acute lymphoblastic leukemia hematology 2016 standard therapy Belarus 18
867 bone marrow acute myelogenous leukemia hematology 2017 standard therapy Russia 59
868 bone marrow acute lymphoblastic leukemia hematology 2017 standard therapy USA 21
869 bone marrow  severe combined immunodeficiency hematology 2017 standard therapy Turkey 2
870 bone marrow hyper IgM syndrome hematology 2017 standard therapy Finland 2
871 bone marrow acute lymphoblastic leukemia hematology 2017 standard therapy Austria 3
872 bone marrow acute myelogenous leukemia hematology 2017 standard therapy Russia 1
873 bone marrow acute myelogenous leukemia hematology 2017 standard therapy Italy 59
874 bone marrow acute myelogenous leukemia hematology 2017 standard therapy USA 57
875 bone marrow pure red cell aplasia hematology 2017 standard therapy USA 5
876 bone marrow acute lymphoblastic leukemia hematology 2016 standard therapy Italy 6
877 bone marrow acute myelogenous leukemia hematology 2016 standard therapy Italy 64
878 bone marrow acute lymphoblastic leukemia hematology 2016 standard therapy Italy 14
879 peripheral blood acute myelogenous leukemia hematology 2017 standard therapy USA 63
880 peripheral blood chronic myelomonocytic leukaemia hematology 2017 standard therapy Italy 61
881 peripheral blood prolymphocytic leukemia hematology 2017 standard therapy Poland 63
882 peripheral blood acute myelogenous leukemia hematology 2017 standard therapy USA 53
883 peripheral blood acute myelogenous leukemia hematology 2017 standard therapy Italy 16
884 peripheral blood acute lymphoblastic leukemia hematology 2017 standard therapy USA 17
885 peripheral blood T-cell acute lymphoblastic leukemia hematology 2017 standard therapy Greece 28
886 peripheral blood B-cell Acute lymphoblastic leukemia hematology 2017 standard therapy Spain 28
887 peripheral blood acute lymphoblastic leukemia hematology 2017 standard therapy France 36
888 peripheral blood myelofibrosis hematology 2017 standard therapy Netherlands 72
889 peripheral blood myelodysplastic syndrome hematology 2017 standard therapy Belgium 69
890 peripheral blood chronic lymphocytic leukemia hematology 2017 standard therapy USA 51
891 peripheral blood non-Hodgkin lymphoma hematology 2017 standard therapy Norway 56
892 peripheral blood acute lymphoblastic leukemia hematology 2017 standard therapy Australia 43
893 peripheral blood myelodysplastic syndrome hematology 2017 standard therapy USA 63
894 peripheral blood acute myelogenous leukemia hematology 2017 standard therapy USA 57
895 peripheral blood chronic lymphocytic leukemia hematology 2017 standard therapy Germany 7
896 peripheral blood acute lymphoblastic leukemia hematology 2017 standard therapy Poland 21
897 peripheral blood no data n/a 2016 standard therapy Poland 55
898 peripheral blood acute myelogenous leukemia hematology 2016 standard therapy France 32
899 peripheral blood T-cell acute lymphoblastic leukemia hematology 2016 standard therapy Germany 19
900 peripheral blood myelodysplastic syndrome hematology 2016 standard therapy United Kingdom 68
901 peripheral blood acute myelogenous leukemia hematology 2016 standard therapy Germany 59
902 peripheral blood myelodysplastic syndrome - RCMD hematology 2016 standard therapy Czech Republic 32
903 peripheral blood myelodysplastic syndrome hematology 2016 standard therapy Belgium 65
904 peripheral blood myelofibrosis hematology 2016 standard therapy Netherlands 66
905 peripheral blood acute myelogenous leukemia hematology 2016 standard therapy Switzerland 1
906 peripheral blood acute myelogenous leukemia hematology 2016 standard therapy Israel 36
907 peripheral blood acute myelogenous leukemia hematology 2016 standard therapy Germany 66
908 peripheral blood acute myelogenous leukemia hematology 2016 standard therapy Denmark 68
909 peripheral blood myelodysplastic syndrome hematology 2016 standard therapy Spain 15
910 peripheral blood myelodysplastic syndrome hematology 2016 standard therapy Italy 52
911 peripheral blood chronic myelomonocytic leukaemia hematology 2016 standard therapy Finland 53
912 peripheral blood B-cell Acute lymphoblastic leukemia hematology 2017 standard therapy Germany 64
913 peripheral blood acute myelogenous leukemia hematology 2017 standard therapy Netherlands 71
914 peripheral blood primary myelofibrosis hematology 2017 standard therapy Poland 32
915 peripheral blood acute myelogenous leukemia hematology 2017 standard therapy Poland 24
916 peripheral blood acute myelogenous leukemia hematology 2017 standard therapy Germany 62
917 peripheral blood myelofibrosis hematology 2017 standard therapy USA 47
918 peripheral blood blastic plasmacytoid dendritic cell neoplasm hematology 2017 standard therapy Germany 56
919 peripheral blood acute myelogenous leukemia hematology 2017 standard therapy Germany 52
920 peripheral blood acute myelogenous leukemia hematology 2017 standard therapy Poland 66
921 peripheral blood acute lymphoblastic leukemia hematology 2017 standard therapy USA 53
922 peripheral blood acute myelogenous leukemia hematology 2017 standard therapy Sweden 69
923 peripheral blood no data hematology 2017 standard therapy Poland 1
924 peripheral blood myelodysplastic syndrome hematology 2017 standard therapy USA 66
925 peripheral blood acute lymphoblastic leukemia hematology 2017 standard therapy USA 67
926 peripheral blood acute myelogenous leukemia hematology 2017 standard therapy Germany 55
927 peripheral blood non-Hodgkin lymphoma hematology 2017 standard therapy Netherlands 65
928 peripheral blood myelodysplastic syndrome hematology 2017 standard therapy USA 68
929 peripheral blood myelodysplastic syndrome hematology 2017 standard therapy USA 63
930 peripheral blood myelodysplastic syndrome hematology 2017 standard therapy Germany 50
931 peripheral blood acute myelogenous leukemia hematology 2017 standard therapy Sweden 59
932 peripheral blood acute myelogenous leukemia hematology 2017 standard therapy Germany 63
933 peripheral blood acute myelogenous leukemia hematology 2017 standard therapy Israel 37
934 peripheral blood acute myelogenous leukemia hematology 2017 standard therapy USA 23
935 peripheral blood acute lymphoblastic leukemia hematology 2017 standard therapy Israel 6
936 peripheral blood no data n/a 2016 standard therapy Turkey 4
937 peripheral blood leukemia hematology 2016 standard therapy Lithuania 53
938 peripheral blood T-cell acute lymphoblastic leukemia hematology 2016 standard therapy Serbia 21
939 peripheral blood myeloproliferative syndrome hematology 2016 standard therapy Poland 52
940 peripheral blood acute myelogenous leukemia hematology 2016 standard therapy France 63
941 peripheral blood no data n/a 2016 standard therapy Poland 44
942 peripheral blood acute myelogenous leukemia hematology 2016 standard therapy Czech Republic 60
943 peripheral blood T-cell acute lymphoblastic leukemia hematology 2016 standard therapy Austria 41
944 peripheral blood primary myelofibrosis hematology 2016 standard therapy Switzerland 67
945 peripheral blood myelodysplastic syndrome hematology 2016 standard therapy United Kingdom 20
946 peripheral blood acute myelogenous leukemia hematology 2016 standard therapy Brazil 37
947 peripheral blood myelodysplastic syndrome hematology 2016 standard therapy France 60
948 peripheral blood acute myelogenous leukemia hematology 2016 standard therapy Germany 61
949 peripheral blood acute myelogenous leukemia hematology 2016 standard therapy Turkey 51
950 peripheral blood acute lymphoblastic leukemia hematology 2016 standard therapy France 28
951 peripheral blood acute myelogenous leukemia hematology 2016 standard therapy Poland 65
952 peripheral blood acute myelogenous leukemia hematology 2016 standard therapy Italy 53
953 peripheral blood Lymphoblastic Lymphoma hematology 2016 standard therapy Italy 33
954 peripheral blood acute lymphoblastic leukemia hematology 2016 standard therapy Slovakia 30
955 peripheral blood myelodysplastic syndrome hematology 2016 standard therapy Belgium 9
956 peripheral blood myeloma multiplex hematology 2016 standard therapy Poland 38
957 peripheral blood acute lymphoblastic leukemia hematology 2016 standard therapy Poland 39
958 peripheral blood severe aplastic anaemia hematology 2017 standard therapy Russia 16
959 peripheral blood secondary acute myelogenous leukemia hematology 2017 standard therapy Austria 24
960 peripheral blood acute myelogenous leukemia hematology 2017 standard therapy Turkey 26
961 peripheral blood acute myelogenous leukemia hematology 2017 standard therapy Germany 46
962 peripheral blood acute myelogenous leukemia hematology 2017 standard therapy USA 68
963 peripheral blood non-Hodgkin lymphoma hematology 2017 standard therapy USA 55
964 peripheral blood acute myelogenous leukemia hematology 2017 standard therapy USA 71
965 peripheral blood acute myelogenous leukemia hematology 2017 standard therapy USA 53
966 peripheral blood chronic myelomonocytic leukaemia hematology 2017 standard therapy Germany 72
967 peripheral blood acute myelogenous leukemia hematology 2017 standard therapy Poland 58
968 peripheral blood myelodysplastic syndrome hematology 2017 standard therapy France 61
969 peripheral blood no data hematology 2017 standard therapy Canada 55
970 peripheral blood acute lymphoblastic leukemia hematology 2017 standard therapy USA 64
971 peripheral blood myeloma multiplex hematology 2017 standard therapy USA 57
972 peripheral blood myelodysplastic syndrome hematology 2017 standard therapy USA 61
973 peripheral blood myelodysplastic syndrome hematology 2017 standard therapy Canada 22
974 peripheral blood myelodysplastic syndrome hematology 2016 standard therapy Austria 61
975 peripheral blood acute myelogenous leukemia hematology 2016 standard therapy New Zealand 59
976 peripheral blood acute myelogenous leukemia hematology 2016 standard therapy Australia 62
977 peripheral blood acute myelogenous leukemia hematology 2016 standard therapy Germany 65
978 peripheral blood acute myelogenous leukemia hematology 2016 standard therapy Portugal 41
979 peripheral blood myelodysplastic syndrome hematology 2016 standard therapy France 59
980 peripheral blood SAA / Amyloidosis hematology 2016 standard therapy United Kingdom 45
981 peripheral blood chronic myeloid leukemia hematology 2016 standard therapy Finland 46
982 peripheral blood acute myelogenous leukemia hematology 2016 standard therapy Poland 50
983 peripheral blood acute lymphoblastic leukemia hematology 2016 standard therapy Italy 66
984 peripheral blood non-Hodgkin lymphoma hematology 2016 standard therapy Russia 38
985 peripheral blood acute lymphoblastic leukemia hematology 2016 standard therapy Poland 20
986 peripheral blood myelofibrosis hematology 2016 standard therapy France 67
987 peripheral blood B-cell Acute lymphoblastic leukemia hematology 2016 standard therapy Belgium 44
988 peripheral blood non-Hodgkin lymphoma hematology 2016 standard therapy Poland 58
989 peripheral blood acute myelogenous leukemia hematology 2016 standard therapy Germany 72
990 peripheral blood acute myelogenous leukemia hematology 2016 standard therapy United Kingdom 68
991 peripheral blood myelodysplastic syndrome hematology 2016 standard therapy Germany 63
992 peripheral blood acute lymphoblastic leukemia hematology 2016 standard therapy France 56
993 peripheral blood acute myelogenous leukemia hematology 2016 standard therapy Poland 54
994 peripheral blood acute myelogenous leukemia hematology 2016 standard therapy Poland 24
995 peripheral blood acute lymphoblastic leukemia hematology 2016 standard therapy Greece 9
996 peripheral blood chronic myeloid leukemia hematology 2016 standard therapy Germany 40
997 peripheral blood myelodysplastic syndrome hematology 2016 standard therapy Germany 15
998 peripheral blood acute myelogenous leukemia with myelodysplastic syndrome hematology 2017 standard therapy Germany 64
999 peripheral blood follicular CA hematology 2017 standard therapy South Africa 42
1000 peripheral blood myelodysplastic syndrome hematology 2017 standard therapy Canada 63
1001 peripheral blood chronic lymphocytic leukemia hematology 2017 standard therapy USA 65
1002 peripheral blood acute lymphoblastic leukemia hematology 2017 standard therapy USA 35
1003 peripheral blood other myleofibrosis hematology 2017 standard therapy USA 71
1004 peripheral blood acute myelogenous leukemia hematology 2017 standard therapy USA 64
1005 peripheral blood myelodysplastic syndrome hematology 2017 standard therapy USA 69
1006 peripheral blood acute myelogenous leukemia hematology 2017 standard therapy Italy 39
1007 peripheral blood myelodysplastic syndrome hematology 2017 standard therapy USA 54
1008 peripheral blood prolymphocytic leukemia hematology 2017 standard therapy Belgium 38
1009 peripheral blood myelodysplastic syndrome hematology 2017 standard therapy France 65
1010 peripheral blood acute lymphoblastic leukemia hematology 2017 standard therapy USA 23
1011 peripheral blood acute myelogenous leukemia hematology 2017 standard therapy Slovakia 54
1012 peripheral blood acute myelogenous leukemia hematology 2017 standard therapy Poland 35
1013 peripheral blood acute myelogenous leukemia hematology 2017 standard therapy Finland 46
1014 peripheral blood myelofibrosis hematology 2017 standard therapy Germany 29
1015 peripheral blood myelodysplastic syndrome hematology 2017 standard therapy Germany 63
1016 peripheral blood acute lymphoblastic leukemia hematology 2017 standard therapy Czech Republic 12
1017 peripheral blood acute myelogenous leukemia hematology 2017 standard therapy Germany 29
1018 peripheral blood no data hematology 2017 standard therapy Germany 65
1019 peripheral blood chronic granulomatous disease hematology 2017 standard therapy Poland 4
1020 peripheral blood no data hematology 2017 standard therapy Russia 36
1021 peripheral blood acute myelogenous leukemia hematology 2017 standard therapy Turkey 58
1022 peripheral blood myelodysplastic syndrome hematology 2017 standard therapy Turkey 54
1023 peripheral blood acute lymphoblastic leukemia hematology 2017 standard therapy Netherlands 51
1024 peripheral blood acute myelogenous leukemia hematology 2017 standard therapy Germany 60
1025 peripheral blood myelodysplastic syndrome hematology 2017 standard therapy Germany 49
1026 peripheral blood acute lymphoblastic leukemia hematology 2017 standard therapy Poland 38
1027 peripheral blood acute myelogenous leukemia hematology 2017 standard therapy Poland 38
1028 peripheral blood acute myelogenous leukemia hematology 2017 standard therapy Hungary 32
1029 peripheral blood acute myelogenous leukemia hematology 2016 standard therapy Poland 40
1030 peripheral blood myelodysplastic syndrome - RAEB hematology 2016 standard therapy Poland 56
1031 peripheral blood no data n/a 2016 standard therapy Sweden 58
1032 peripheral blood Hodgkin’s lymphoma hematology 2016 standard therapy Germany 32
1033 peripheral blood acute myelogenous leukemia hematology 2016 standard therapy Germany 32
1034 peripheral blood acute myelogenous leukemia hematology 2016 standard therapy Germany 66
1035 peripheral blood T Cell Lymphoma/ NOS - Not otherwise specified hematology 2016 standard therapy Germany 55
1036 peripheral blood acute myelogenous leukemia hematology 2016 standard therapy Germany 43
1037 peripheral blood no data n/a 2016 standard therapy Czech Republic 59
1038 peripheral blood aplastic anaemia hematology 2016 standard therapy United Kingdom 23
1039 peripheral blood myelodysplastic syndrome hematology 2016 standard therapy Germany 73
1040 peripheral blood myelofibrosis hematology 2016 standard therapy Israel 72
1041 peripheral blood acute lymphoblastic leukemia hematology 2016 standard therapy Australia 61
1042 peripheral blood primary myelofibrosis hematology 2016 standard therapy Germany 67
1043 peripheral blood myelodysplastic syndrome hematology 2016 standard therapy Ireland 47
1044 peripheral blood no data n/a 2016 standard therapy Germany 17
1045 peripheral blood no data n/a 2016 standard therapy France 59
1046 peripheral blood acute myelogenous leukemia hematology 2016 standard therapy Germany 66
1047 peripheral blood myelodysplastic syndrome hematology 2017 standard therapy Poland 46
1048 peripheral blood myelodysplastic syndrome hematology 2017 standard therapy USA 53
1049 peripheral blood acute myelogenous leukemia hematology 2017 standard therapy Netherlands 66
1050 peripheral blood acute myelogenous leukemia hematology 2017 standard therapy Netherlands 75
1051 peripheral blood acute myelogenous leukemia hematology 2017 standard therapy Italy 61
1052 peripheral blood acute myelogenous leukemia hematology 2017 standard therapy Sweden 63
1053 peripheral blood acute myelogenous leukemia hematology 2017 standard therapy Poland 60
1054 peripheral blood myeloma multiplex hematology 2017 standard therapy Germany 56
1055 peripheral blood acute myelogenous leukemia hematology 2017 standard therapy Lithuania 59
1056 peripheral blood acute myelogenous leukemia hematology 2017 standard therapy Italy 45
1057 peripheral blood hemophagocytosis hematology 2017 standard therapy USA 52
1058 peripheral blood acute lymphoblastic leukemia hematology 2017 standard therapy Brazil 12
1059 peripheral blood non-Hodgkin lymphoma hematology 2017 standard therapy Norway 57
1060 peripheral blood acute lymphoblastic leukemia hematology 2017 standard therapy Belgium 19
1061 peripheral blood chronic lymphocytic leukemia hematology 2017 standard therapy USA 45
1062 peripheral blood non-Hodgkin lymphoma hematology 2017 standard therapy USA 65
1063 peripheral blood acute myelogenous leukemia hematology 2017 standard therapy Germany 64
1064 peripheral blood myelodysplastic syndrome hematology 2017 standard therapy Belgium 71
1065 peripheral blood acute myelogenous leukemia hematology 2017 standard therapy Turkey 46
1066 peripheral blood acute myelogenous leukemia hematology 2017 standard therapy Belgium 55
1067 peripheral blood no data hematology 2017 standard therapy Poland 39
1068 peripheral blood aplastic anaemia hematology 2017 standard therapy United Kingdom 23
1069 peripheral blood myelofibrosis hematology 2017 standard therapy USA 62
1070 peripheral blood myelodysplastic syndrome hematology 2017 standard therapy Germany 50
1071 peripheral blood acute myelogenous leukemia hematology 2017 standard therapy Canada 57
1072 peripheral blood non-Hodgkin lymphoma hematology 2017 standard therapy Italy 58
1073 peripheral blood chronic myelomonocytic leukaemia hematology 2017 standard therapy Germany 54
1074 peripheral blood acute myelogenous leukemia hematology 2017 standard therapy Italy 32
1075 peripheral blood acute myelogenous leukemia hematology 2017 standard therapy France 75
1076 peripheral blood non-Hodgkin lymphoma hematology 2017 standard therapy USA 42
1077 peripheral blood myelodysplastic syndrome hematology 2017 standard therapy USA 63
1078 peripheral blood acute lymphoblastic leukemia hematology 2017 standard therapy Australia 60
1079 peripheral blood acute myelogenous leukemia hematology 2017 standard therapy Germany 53
1080 peripheral blood myelodysplastic syndrome hematology 2017 standard therapy Germany 67
1081 peripheral blood acute lymphoblastic leukemia hematology 2017 standard therapy USA 33
1082 peripheral blood acute myelogenous leukemia hematology 2017 standard therapy Poland 64
1083 peripheral blood non-Hodgkin lymphoma hematology 2017 standard therapy Germany 56
1084 peripheral blood acute myelogenous leukemia hematology 2017 standard therapy Germany 65
1085 peripheral blood B-cell Chronic lymphoblastic leukemia hematology 2017 standard therapy Germany 48
1086 peripheral blood acute myelogenous leukemia hematology 2016 standard therapy Poland 18
1087 peripheral blood adrenoleukodystrophy metabolic 2016 standard therapy Poland 1
1088 peripheral blood acute myelogenous leukemia hematology 2016 standard therapy Italy 31
1089 peripheral blood no data n/a 2016 standard therapy Poland 28
1090 peripheral blood acute myelogenous leukemia hematology 2016 standard therapy Sweden 35
1091 peripheral blood no data n/a 2016 standard therapy Czech Republic 1
1092 peripheral blood Wiskott-Aldrich syndrome hematology 2016 standard therapy Poland 1
1093 peripheral blood no data n/a 2016 standard therapy Belgium 30
1094 peripheral blood non-Hodgkin lymphoma hematology 2017 standard therapy Poland 36
1095 peripheral blood T-cell acute lymphoblastic leukemia hematology 2017 standard therapy Poland 7
1096 peripheral blood myelofibrosis hematology 2017 standard therapy USA 62
1097 peripheral blood no data hematology 2017 standard therapy Kanada 32
1098 peripheral blood acute myelogenous leukemia hematology 2017 standard therapy France 63
1099 peripheral blood non-Hodgkin lymphoma hematology 2017 standard therapy France 63
1100 peripheral blood primary Immunodeficiency hematology 2017 standard therapy Russia 4
1101 peripheral blood myelodysplastic syndrome hematology 2017 standard therapy France 39
1102 peripheral blood acute lymphoblastic leukemia hematology 2017 standard therapy USA 62
1103 peripheral blood acute myelogenous leukemia hematology 2017 standard therapy USA 65
1104 peripheral blood chronic myelomonocytic leukaemia hematology 2017 standard therapy USA 58
1105 peripheral blood acute myelogenous leukemia hematology 2017 standard therapy Italy 67
1106 peripheral blood acute myelogenous leukemia hematology 2017 standard therapy USA 58
1107 peripheral blood acute lymphoblastic leukemia hematology 2017 standard therapy Netherlands 51
1108 peripheral blood myelodysplastic syndrome hematology 2017 standard therapy USA 69
1109 peripheral blood acute lymphoblastic leukemia hematology 2017 standard therapy Poland 19
1110 peripheral blood myelodysplastic syndrome hematology 2017 standard therapy Switzerland 67
1111 peripheral blood acute myelogenous leukemia hematology 2017 standard therapy Poland 43
1112 peripheral blood non-Hodgkin lymphoma hematology 2017 standard therapy USA 68
1113 peripheral blood myelodysplastic syndrome hematology 2017 standard therapy Amsterdam 69
1114 peripheral blood acute lymphoblastic leukemia hematology 2017 standard therapy Israel 11
1115 peripheral blood acute lymphoblastic leukemia hematology 2017 standard therapy Canada 4
1116 peripheral blood acute myelogenous leukemia hematology 2017 standard therapy Poland 42
1117 peripheral blood myeloproliferative neoplasms hematology 2017 standard therapy Poland 7
1118 peripheral blood no data hematology 2017 standard therapy Poland 58
1119 peripheral blood chronic lymphocytic leukemia hematology 2016 standard therapy Germany 62
1120 peripheral blood acute myelogenous leukemia hematology 2016 standard therapy France 47
1121 peripheral blood myelodysplastic syndrome hematology 2016 standard therapy France 67
1122 peripheral blood acute myelogenous leukemia hematology 2016 standard therapy Lithuania 15
1123 peripheral blood Hodgkin’s lymphoma hematology 2016 standard therapy United Kingdom 18
1124 peripheral blood acute myelogenous leukemia hematology 2016 standard therapy Czech Republic 37
1125 peripheral blood acute lymphoblastic leukemia hematology 2016 standard therapy France 24
1126 peripheral blood acute lymphoblastic leukemia hematology 2016 standard therapy Canada 13
1127 peripheral blood acute myelogenous leukemia hematology 2016 standard therapy Hungary 57
1128 peripheral blood acute myelogenous leukemia hematology 2016 standard therapy Belgium 56
1129 peripheral blood acute myelogenous leukemia hematology 2016 standard therapy France 38
1130 peripheral blood acute myelogenous leukemia hematology 2016 standard therapy France 52
1131 peripheral blood T-cell acute lymphoblastic leukemia hematology 2017 standard therapy Australia 25
1132 peripheral blood acute myelogenous leukemia hematology 2017 standard therapy Canada 55
1133 peripheral blood acute myelogenous leukemia hematology 2017 standard therapy Germany 68
1134 peripheral blood myelodysplastic syndrome hematology 2017 standard therapy USA 76
1135 peripheral blood acute myelogenous leukemia hematology 2017 standard therapy Poland 52
1136 peripheral blood acute lymphoblastic leukemia hematology 2017 standard therapy Canada 41
1137 peripheral blood acute myelogenous leukemia hematology 2017 standard therapy Russia 49
1138 peripheral blood myelofibrosis hematology 2017 standard therapy USA 62
1139 peripheral blood primary Immunodeficiency hematology 2017 standard therapy Russia 2
1140 peripheral blood acute myelogenous leukemia hematology 2017 standard therapy Poland 60
1141 peripheral blood acute myelogenous leukemia hematology 2017 standard therapy Germany 65
1142 peripheral blood acute myelogenous leukemia hematology 2017 standard therapy USA 51
1143 peripheral blood acute myelogenous leukemia hematology 2017 standard therapy Germany 35
1144 peripheral blood no data hematology 2017 standard therapy Poland 53
1145 peripheral blood myelodysplastic syndrome hematology 2017 standard therapy Belgium 70
1146 peripheral blood acute lymphoblastic leukemia hematology 2017 standard therapy Germany 64
1147 peripheral blood non-Hodgkin lymphoma hematology 2017 standard therapy Poland 52
1148 peripheral blood chronic myeloid leukemia hematology 2017 standard therapy USA 74
1149 peripheral blood acute lymphoblastic leukemia hematology 2017 standard therapy Poland 30
1150 peripheral blood acute myelogenous leukemia hematology 2017 standard therapy USA 57
1151 peripheral blood acute myelogenous leukemia hematology 2017 standard therapy Germany 31
1152 peripheral blood acute myelogenous leukemia hematology 2017 standard therapy Italy 64
1153 peripheral blood acute myelogenous leukemia hematology 2017 standard therapy Germany 60
1154 peripheral blood acute myelogenous leukemia hematology 2017 standard therapy Germany 49
1155 peripheral blood severe aplastic anaemia hematology 2017 standard therapy Poland 27
1156 peripheral blood acute myelogenous leukemia hematology 2017 standard therapy USA 53
1157 peripheral blood acute myelogenous leukemia hematology 2017 standard therapy USA 22
1158 peripheral blood severe aplastic anaemia hematology 2017 standard therapy Poland 32
1159 peripheral blood chronic myelomonocytic leukemia, minimal residual disease hematology 2016 standard therapy Poland 50
1160 peripheral blood myeloma multiplex hematology 2016 standard therapy Germany 63
1161 peripheral blood Fanconi anaemia hematology 2016 standard therapy Estonia 7
1162 peripheral blood plasma cell disorder hematology 2016 standard therapy France 47
1163 peripheral blood acute myelogenous leukemia hematology 2016 standard therapy Germany 35
1164 peripheral blood acute myelogenous leukemia hematology 2016 standard therapy Germany 72
1165 peripheral blood myeloma multiplex hematology 2016 standard therapy Poland 51
1166 peripheral blood acute lymphoblastic leukemia hematology 2016 standard therapy Spain 58
1167 peripheral blood myelodysplastic syndrome hematology 2016 standard therapy Estonia 62
1168 peripheral blood acute myelogenous leukemia hematology 2016 standard therapy Hungary 46
1169 peripheral blood acute lymphoblastic leukemia hematology 2016 standard therapy Hungary 20
1170 peripheral blood acute myelogenous leukemia hematology 2016 standard therapy Italy 51
1171 peripheral blood primary Immunodeficiency hematology 2016 standard therapy Russia 5
1172 peripheral blood acute myelogenous leukemia hematology 2016 standard therapy United Kingdom 62
1173 peripheral blood acute myelogenous leukemia hematology 2016 standard therapy Germany 69
1174 peripheral blood acute myelogenous leukemia hematology 2016 standard therapy Australia 51
1175 peripheral blood no data n/a 2016 standard therapy Netherlands 58
1176 peripheral blood acute myelogenous leukemia hematology 2016 standard therapy Spain 38
1177 peripheral blood acute lymphoblastic leukemia hematology 2016 standard therapy Lithuania 23
1178 peripheral blood chronic myeloid leukemia hematology 2016 standard therapy Germany 62
1179 peripheral blood Hodgkin’s lymphoma hematology 2016 standard therapy Germany 32
1180 peripheral blood Hurler syndrome hematology 2017 standard therapy United Kingdom 2
1181 peripheral blood myeloma multiplex hematology 2017 standard therapy Germany 44
1182 peripheral blood myelodysplastic syndrome hematology 2017 standard therapy Poland 60
1183 peripheral blood acute lymphoblastic leukemia hematology 2017 standard therapy USA 24
1184 peripheral blood acute myelogenous leukemia hematology 2017 standard therapy United Kingdom 51
1185 peripheral blood chronic myeloproliferative neoplasm blast crisis hematology 2017 standard therapy Germany 29
1186 peripheral blood acute lymphoblastic leukemia hematology 2017 standard therapy Poland 43
1187 peripheral blood myelodysplastic syndrome hematology 2017 standard therapy France 68
1188 peripheral blood chronic myeloid leukemia hematology 2017 standard therapy Turkey 29
1189 peripheral blood severe aplastic anaemia hematology 2017 standard therapy Poland 14
1190 peripheral blood Niemann–Pick disease hematology 2017 standard therapy Poland 2
1191 peripheral blood acute lymphoblastic leukemia hematology 2017 standard therapy Iran 17
1192 peripheral blood myelodysplastic syndrome hematology 2017 standard therapy Poland 3
1193 peripheral blood non-Hodgkin lymphoma hematology 2017 standard therapy USA 63
1194 peripheral blood Common variable immunodeficiency, relapsed hemophagocytic syndrome hematology 2017 standard therapy Germany 44
1195 peripheral blood acute myelogenous leukemia hematology 2016 standard therapy United Kingdom 58
1196 peripheral blood acute lymphoblastic leukemia hematology 2016 standard therapy Poland 56
1197 peripheral blood myelodysplastic syndrome hematology 2016 standard therapy Austria 60
1198 peripheral blood acute myelogenous leukemia hematology 2016 standard therapy Australia 62
1199 peripheral blood no data n/a 2016 standard therapy Czech Republic 45
1200 peripheral blood chronic lymphocytic leukemia hematology 2016 standard therapy Slovakia 52
1201 peripheral blood acute myelogenous leukemia hematology 2016 standard therapy France 40
1202 peripheral blood no data n/a 2016 standard therapy Netherlands 70
1203 peripheral blood acute myelogenous leukemia hematology 2017 standard therapy France 65
1204 peripheral blood myelofibrosis hematology 2017 standard therapy Spain 63
1205 peripheral blood diffuse large B-cell lymphoma hematology 2017 standard therapy Germany 61
1206 peripheral blood myelodysplastic syndrome hematology 2017 standard therapy USA 56
1207 peripheral blood acute myelogenous leukemia hematology 2017 standard therapy Italy 48
1208 peripheral blood myelodysplastic syndrome hematology 2017 standard therapy Austria 54
1209 peripheral blood myelofibrosis hematology 2017 standard therapy Denmark 63
1210 peripheral blood acute myelogenous leukemia hematology 2017 standard therapy Hungary 47
1211 peripheral blood no data n/a 2017 standard therapy France 39
1212 peripheral blood acute myelogenous leukemia hematology 2017 standard therapy Poland 54
1213 peripheral blood Langerhans Lymphohistiocytosis hematology 2017 standard therapy Czech Republic 2
1214 peripheral blood myelodysplastic syndrome hematology 2017 standard therapy USA 75
1215 peripheral blood myelodysplastic syndrome hematology 2017 standard therapy Slovakia 64
1216 peripheral blood chronic lymphocytic leukemia hematology 2017 standard therapy Belgium 57
1217 peripheral blood acute myelogenous leukemia hematology 2017 standard therapy Russia 32
1218 peripheral blood acute lymphoblastic leukemia hematology 2017 standard therapy USA 53
1219 peripheral blood acute myelogenous leukemia hematology 2017 standard therapy Germany 47
1220 peripheral blood acute lymphoblastic leukemia hematology 2017 standard therapy France 43
1221 peripheral blood acute myelogenous leukemia hematology 2017 standard therapy Italy 48
1222 peripheral blood non-Hodgkin lymphoma hematology 2017 standard therapy France 56
1223 peripheral blood non-Hodgkin lymphoma hematology 2017 standard therapy Italy 47
1224 peripheral blood acute lymphoblastic leukemia hematology 2017 standard therapy Poland 3
1225 peripheral blood acute myelogenous leukemia hematology 2017 standard therapy Spain 20
1226 peripheral blood myelodysplastic syndrome hematology 2017 standard therapy Croatia 64
1227 peripheral blood myelofibrosis hematology 2017 standard therapy Germany 66
1228 peripheral blood acute myelogenous leukemia hematology 2017 standard therapy USA 44
1229 peripheral blood no data n/a 2016 standard therapy Poland 43
1230 peripheral blood acute myelogenous leukemia hematology 2016 standard therapy Poland 18
1231 peripheral blood X-linked lymphoproliferative disease hematology 2016 standard therapy Russia 12
1232 peripheral blood chronic lymphocytic leukemia hematology 2016 standard therapy Sweden 61
1233 peripheral blood acute myelogenous leukemia hematology 2016 standard therapy Germany 66
1234 peripheral blood no data n/a 2016 standard therapy Netherlands 69
1235 peripheral blood acute lymphoblastic leukemia hematology 2016 standard therapy Columbia 43
1236 peripheral blood acute myelogenous leukemia hematology 2016 standard therapy Germany 64
1237 peripheral blood Hodgkin’s lymphoma hematology 2016 standard therapy Poland 31
1238 peripheral blood acute myelogenous leukemia hematology 2016 standard therapy Czech Republic 54
1239 peripheral blood T-cell leukemia/lymphoma hematology 2016 standard therapy Canada 31
1240 peripheral blood acute myelogenous leukemia hematology 2016 standard therapy Poland 54
1241 peripheral blood primary myelofibrosis hematology 2016 standard therapy Germany 50
1242 peripheral blood myelodysplastic syndrome hematology 2017 standard therapy USA 40
1243 peripheral blood non-Hodgkin lymphoma hematology 2017 standard therapy USA 69
1244 peripheral blood acute myelogenous leukemia hematology 2017 standard therapy Poland 27
1245 peripheral blood myeloma multiplex hematology 2017 standard therapy Poland 38
1246 peripheral blood myelodysplastic syndrome hematology 2017 standard therapy Germany 57
1247 peripheral blood non-Hodgkin lymphoma hematology 2017 standard therapy USA 69
1248 peripheral blood acute myelogenous leukemia hematology 2017 standard therapy USA 72
1249 peripheral blood myelodysplastic syndrome hematology 2017 standard therapy Germany 63
1250 peripheral blood acute lymphoblastic leukemia hematology 2017 standard therapy United Kingdom 24
1251 peripheral blood acute myelogenous leukemia hematology 2017 standard therapy USA 72
1252 peripheral blood Hodgkin’s lymphoma hematology 2017 standard therapy USA 25
1253 peripheral blood chronic myeloid leukemia hematology 2017 standard therapy USA 57
1254 peripheral blood myelodysplastic syndrome in Fanconi anaemia hematology 2017 standard therapy Italy 23
1255 peripheral blood chronic myelomonocytic leukaemia hematology 2017 standard therapy Germany 60
1256 peripheral blood myelodysplastic syndrome hematology 2017 standard therapy USA 70
1257 peripheral blood acute lymphoblastic leukemia hematology 2017 standard therapy Poland 10
1258 peripheral blood acute lymphoblastic leukemia hematology 2017 standard therapy Belgium 26
1259 peripheral blood acute myelogenous leukemia hematology 2017 standard therapy Poland 37
1260 peripheral blood acute lymphoblastic leukemia hematology 2017 standard therapy USA 8
1261 peripheral blood no data hematology 2017 standard therapy Switzerland 68
1262 peripheral blood acute myelogenous leukemia hematology 2017 standard therapy USA 71
1263 peripheral blood acute lymphoblastic leukemia hematology 2017 standard therapy Poland 13
1264 peripheral blood myelodysplastic syndrome hematology 2016 standard therapy Germany 37
1265 peripheral blood acute myelogenous leukemia hematology 2016 standard therapy Russia 44
1266 peripheral blood myelodysplastic syndrome hematology 2016 standard therapy Germany 59
1267 peripheral blood non-Hodgkin lymphoma hematology 2016 standard therapy Russia 32
1268 peripheral blood myelodysplastic syndrome hematology 2016 standard therapy Germany 62
1269 peripheral blood acute myelogenous leukemia hematology 2016 standard therapy Poland 55
1270 peripheral blood composite lymphoma hematology 2016 standard therapy Germany 51
1271 peripheral blood acute myelogenous leukemia hematology 2016 standard therapy Italy 30
1272 peripheral blood acute lymphoblastic leukemia hematology 2016 standard therapy Germany 33
1273 peripheral blood myelodysplastic syndrome hematology 2016 standard therapy Italy 58
1274 peripheral blood high-risk acute lymphoblastic leukemia hematology 2016 standard therapy Poland 5
1275 peripheral blood acute myelogenous leukemia M2/M4 hematology 2016 standard therapy Germany 59
1276 peripheral blood non-Hodgkin lymphoma hematology 2016 standard therapy Netherlands 39
1277 peripheral blood acute lymphoblastic leukemia hematology 2016 standard therapy Italy 21
1278 peripheral blood acute myelogenous leukemia hematology 2016 standard therapy Spain 50
1279 peripheral blood plasma cell disorder hematology 2016 standard therapy France 54
1280 peripheral blood acute myelogenous leukemia hematology 2016 standard therapy United Kingdom 47
1281 peripheral blood acute myelogenous leukemia hematology 2016 standard therapy Canada 47
1282 peripheral blood myelodysplastic syndrome hematology 2016 standard therapy Germany 67
1283 peripheral blood myelodysplastic syndrome hematology 2016 standard therapy Germany 62
1284 peripheral blood acute myelogenous leukemia hematology 2016 standard therapy Italy 63
1285 peripheral blood acute myelogenous leukemia hematology 2016 standard therapy Poland 19
1286 peripheral blood T-cell-prolymphocytic leukemia hematology 2016 standard therapy United Kingdom 61
1287 peripheral blood myelodysplastic syndrome hematology 2016 standard therapy USA 69
1288 peripheral blood acute lymphoblastic leukemia hematology 2016 standard therapy France 35
1289 peripheral blood severe aplastic anaemia hematology 2016 standard therapy Russia 18
1290 peripheral blood myelodysplastic syndrome hematology 2016 standard therapy Germany 66
1291 peripheral blood B-cell Acute lymphoblastic leukemia hematology 2017 standard therapy Germany 44
1292 peripheral blood myelodysplastic syndrome hematology 2017 standard therapy Lithuania 53
1293 peripheral blood other malignancy hematology 2017 standard therapy France 59
1294 peripheral blood acute lymphoblastic leukemia hematology 2017 standard therapy Italy 57
1295 peripheral blood acute myelogenous leukemia hematology 2017 standard therapy Russia 54
1296 peripheral blood acute myelogenous leukemia hematology 2017 standard therapy USA 61
1297 peripheral blood acute myelogenous leukemia hematology 2017 standard therapy Hungary 40
1298 peripheral blood non-Hodgkin lymphoma hematology 2017 standard therapy Netherlands 53
1299 peripheral blood acute myelogenous leukemia hematology 2017 standard therapy Finland 58
1300 peripheral blood chronic myelomonocytic leukaemia hematology 2017 standard therapy United Kingdom 51
1301 peripheral blood acute myelogenous leukemia hematology 2017 standard therapy Germany 68
1302 peripheral blood acute lymphoblastic leukemia hematology 2017 standard therapy Poland 56
1303 peripheral blood acute myelogenous leukemia hematology 2017 standard therapy Germany 62
1304 peripheral blood acute myelogenous leukemia hematology 2017 standard therapy Canada 46
1305 peripheral blood primary myelofibrosis hematology 2017 standard therapy Germany 29
1306 peripheral blood acute myelogenous leukemia hematology 2017 standard therapy Germany 62
1307 peripheral blood acute myelogenous leukemia hematology 2017 standard therapy Germany 59
1308 peripheral blood acute lymphoblastic leukemia hematology 2016 standard therapy Germany 27
1309 peripheral blood acute lymphoblastic leukemia hematology 2016 standard therapy Poland 30
1310 peripheral blood acute myelogenous leukemia hematology 2016 standard therapy Turkey 55
1311 peripheral blood acute myelogenous leukemia hematology 2016 standard therapy Israel 63
1312 peripheral blood acute lymphoblastic leukemia hematology 2016 standard therapy Turkey 37
1313 peripheral blood acute myelogenous leukemia hematology 2016 standard therapy Germany 66
1314 peripheral blood acute lymphoblastic leukemia hematology 2016 standard therapy Turkey 38
1315 peripheral blood acute myelogenous leukemia hematology 2016 standard therapy Germany 65
1316 peripheral blood acute myelogenous leukemia hematology 2016 standard therapy Poland 46
1317 peripheral blood acute myelogenous leukemia hematology 2016 standard therapy Germany 18
1318 peripheral blood Hodgkin’s lymphoma hematology 2016 standard therapy Netherlands 38
1319 peripheral blood acute myelogenous leukemia hematology 2016 standard therapy Turkey 48
1320 peripheral blood myelodysplastic syndrome hematology 2016 standard therapy Germany 61
1321 peripheral blood acute myelogenous leukemia hematology 2016 standard therapy France 67
1322 peripheral blood chronic lymphocytic leukemia hematology 2017 standard therapy Poland 47
1323 peripheral blood osteopetrosis hematology 2017 standard therapy Israel 3
1324 peripheral blood acute myelogenous leukemia hematology 2017 standard therapy France 56
1325 peripheral blood acute myelogenous leukemia hematology 2017 standard therapy Italy 55
1326 peripheral blood acute lymphoblastic leukemia hematology 2017 standard therapy Canada 56
1327 peripheral blood myelodysplastic syndrome hematology 2017 standard therapy Lithuania 65
1328 peripheral blood acute myelogenous leukemia hematology 2017 standard therapy Switzerland 75
1329 peripheral blood acute myelogenous leukemia hematology 2017 standard therapy USA 69
1330 peripheral blood acute myelogenous leukemia hematology 2017 standard therapy USA 51
1331 peripheral blood T-cell acute lymphoblastic leukemia hematology 2017 standard therapy Australia 30
1332 peripheral blood chronic lymphocytic leukemia hematology 2017 standard therapy Estonia 67
1333 peripheral blood acute myelogenous leukemia hematology 2017 standard therapy USA 70
1334 peripheral blood acute myelogenous leukemia hematology 2017 standard therapy Belgium 34
1335 peripheral blood myelodysplastic syndrome hematology 2017 standard therapy USA 68
1336 peripheral blood myeloproliferative neoplasms hematology 2017 standard therapy Poland 7
1337 peripheral blood acute myelogenous leukemia hematology 2017 standard therapy Poland 52
1338 peripheral blood acute lymphoblastic leukemia hematology 2017 standard therapy Poland 59
1339 peripheral blood myelofibrosis hematology 2017 standard therapy United Kingdom 55
1340 peripheral blood acute myelogenous leukemia hematology 2017 standard therapy Poland 62
1341 peripheral blood myelodysplastic syndrome hematology 2017 standard therapy Poland 59
1342 peripheral blood acute myelogenous leukemia hematology 2017 standard therapy Canada 67
1343 peripheral blood acute myelogenous leukemia hematology 2017 standard therapy USA 67
1344 peripheral blood β - Thalassemia Major hematology 2017 standard therapy India 4
1345 peripheral blood acute myelogenous leukemia hematology 2017 standard therapy Czech Republic 48
1346 peripheral blood acute myelogenous leukemia hematology 2017 standard therapy Poland 53
1347 peripheral blood acute myelogenous leukemia hematology 2017 standard therapy Germany 55
1348 peripheral blood acute myelogenous leukemia hematology 2017 standard therapy Czech Republic 62
1349 peripheral blood no data n/a 2016 standard therapy Germany 71
1350 peripheral blood acute myelogenous leukemia hematology 2016 standard therapy Germany 46
1351 peripheral blood acute myelogenous leukemia hematology 2016 standard therapy Germany 29
1352 peripheral blood myelodysplastic syndrome hematology 2016 standard therapy Czech Republic 56
1353 peripheral blood acute myelogenous leukemia hematology 2016 standard therapy France 32
1354 peripheral blood acute myelogenous leukemia hematology 2016 standard therapy Czech Republic 49
1355 peripheral blood myelodysplastic syndrome hematology 2016 standard therapy Germany 50
1356 peripheral blood acute myelogenous leukemia hematology 2016 standard therapy Poland 64
1357 peripheral blood acute myelogenous leukemia hematology 2016 standard therapy Poland 42
1358 peripheral blood acute myelogenous leukemia hematology 2016 standard therapy Germany 13
1359 peripheral blood acute myelogenous leukemia hematology 2016 standard therapy Slovakia 8
1360 peripheral blood acute myelogenous leukemia hematology 2016 standard therapy Belgium 46
1361 peripheral blood refractory anemia with excess blasts hematology 2016 standard therapy United Kingdom 62
{{$index+1}} {{item.source}} {{item.indication}} {{item.area}} {{item.year}} {{item.therapy}} {{item.country}} {{item.age | number}}

Last update: 31.12.2017